var title_f15_18_15648="TB of the spine Pott disease 3";
var content_f15_18_15648=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F86253&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F86253&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Tuberculosis of the spine (Pott disease)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 336px; height: 412px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    MRI of 17-year-old fisherman (coronal section) showing a large tuberculous paraspinal abscess and pleural involvement.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Malcolm McDonald, PhD, FRACP, FRCPA.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_18_15648=[""].join("\n");
var outline_f15_18_15648=null;
var title_f15_18_15649="Spigelian hernia imaging";
var content_f15_18_15649=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F68967&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F68967&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Spigelian hernia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 398px; height: 352px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFgAY4DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDhTEJJhhSB2Ht61u2UZhhB3Z9s1Qt0UsCBg5HBOM1bnl2qFA2gc0AR3rO5+V8g9qq7jtGcgg1I0wYHJHH6VDkZycEH360ASRJsOR37+lPlDAqwzycNUPmDBy3yinRzAscjk/pQBq6a0nmF1iVlKnJZsDI9Rj61bUlnEbnKt8xyecf5NVbIxx27AHA6ZB5/EVM0yoq4+92I6mgC/d3I+w7U5BOARWS92M9TnPbjNNv5WkiUpnIJOPb1rOQlgS3T3oA0beb95ktk564711UZEVsig9Rn0x3rldEhCTebMnyr0BPWti4uwzY45/DHagCe6dmf5VznGVzWdcsY5trKAuc5J4piXTN1IznCn0qC8u96YPr60AXFnAIC7mIIAI7U4O00yxxjJznnpispblmhDSDKA1DJdtbSCZSQ38/rQB39nHBaxr57jBH8I5NaWitZ3JuDGrbi4UFuhI61zWlSnVoEW33Zbgqpzzjrit9lTRtPEasfNzlj6E0AaOpwAWu4dOcL16VkXN5CjEyBmyMnJ6nFAv8AzbZV3gjJ6n171kajI2VbcQxA6dzQBXn1VVk3JH95v4jWraeI0traJWjjMxJIUnGfrXIXh2SMwICsemc5rKW9c34PXaMc0AesQ6/NJpLKm0MXIBHemy6pHc2iM8YV9h3DPfNcfZXodChYqSOAT0NW4rkTp5cOQ+7BJHQUAdbYyW8oJ2ALnHBzmuosrS3kjAKZxgYArjtPGDHnHpwOvvXTJfGJwoOOMgge1AGlfaTp7WsW5PLdcgEHFcXq+lNZ3DTQhZI27jt9a7hJo7y1jjkYB25GO9cr40ujpiwxqh3OnQDjNAGFby5duRjr04rRjfdHgkAZrCtpWcFgBuJyf8K1IX3KCeh5xigDQjLKBwOecVFLtznJHsKrrIBgnr39abv3gMeB2oAdKFZT7c1k3TiORjzuI4PrWpIQY8EncKybs5zlV69hj60ALHcjA5YccAd6a03ynrkY59aqM5zkYOO1LPKfLKqOOw7UAK8gUEluR1z6VTuJlP1psrErxjNU7hycBcHjpQBUu5S3IOMHGD6Vk3MoBJ7fXmrV1NhmzgduKyLl+Cc9etAFe7mJJOcHvzWZNNhW7EjAqS5lw5JNUCJJpVjiVmd2Cqo7k0AaOg2E2rarb2dsCzysAQB0Hc19k+C9Kj0vSLW2iUBY0Cj39680+DfgCPR7Vb68VXv5lBY/3B6CvaraMRqMcUAWwcAAU/fx0qHkEGh5MAZNAEc8m1Sc8V4r8dNZ2aXHZRvgyyANzzgV6xql2IYnJPQZr5V+KevjVvFEqxsTHbnYPr3oAwEbcxVMkg5/CrttL8vHIHvWNC7MybT8+eK0ISSo9Og/DigDUtDh2bkiq9zdb5MZbjg81JITDaphh83esyRzuwOeOT60ATLKeW6lu3rSifAypA78+lVixXAX8KYWGRlu/NAF4Mc4PpkcZqW3+8uckYH+TVGJzwQcsentWtZFRDuYEegNAF/zhFEi8DjLEDgmq8twO+Ce3NQzOwGd2DkcZqlcv6Y59T096ALjXJyOw5yAatwzFl+ZQzdcn6VjxkEZJGfzzVxZUSLhvqMZoA1BKZMLllXGfl6D8KfIxA5YgfWs+KdTjB+8Mg+lOZwqhVLEAYz60AOZmkPzFQuc8U9lCpySSep9qr28gDMxBwSfam3M+7IyNwoAtxtH5bHcTgEYpoELKVcZPbvms4S/Kyk7c9DVd7jur8nr70Aeh+CdRhtWmtoUCcffIzx0/CmeIZ7hW2OcuOd3c+3vXN+E5H8+dwg2qmMetdZqaie3huQAQgCsPSgCjpEpaJkn+YEfLgYORTbi4V9gkcA7QT2/SpLOAJKz5UIQcHNc9qYKSOE3g5J68mgB95MrEhBwOp9O3FMsNPimkKnILHgiqQxMwLMV5xwtbenhbVlaVgBk4HfPagDZOhvaANLkxsMhsdarIpt5WdRk5xuxXdWskF54b2SlleMBsmuT1IpE+0HJP3T6igDSsL8eWiORuByK2JLkKdwOQRn61yFlEzOd5INdTDYyTIjDLYwpxzQBraQZZ7kFiTHEvbjp0rD17UjdX8quVKZx69K2ruddN09rWIkzMMlu/wCNedi/USEuTv6H2NAG3bJHklABg8Z549atLjaMNtAPOKxbe7DkMnHoDxzV1bjOFXO3oBjkfjQBbJDEAEcHB96RTsYhiMjpgcCofM2hQMd6bLKDgkkKRnIHQ+9AFpnzuUHv2qhqBUw46N3NKGVfunvnrVW8lYqoTg+poAo78sc5AxwKinl4DLyOlMZiO4LY65qtI3BBy2O/rQAPPhSCTg9M+tUbmUYPJ3DqfSmzybev4CqE8ucjjHtQBXu5zkljg46VlzTrucsWx2zzUt2+N3Pvg1k3MhGRnB9BQBDdTjPBNdt8GNBTWfEYvLhQ1vangEdXrz2clmY8fnX0t8D9D+weHLYsuJJR5jHuSaAPXtLgWKBVAwAPStNM1XtgAoHYVZBGc8UAOdsDAqlcTbATUsz4yO9YesXSxQsWYDAoA4f4r+KV0fRZmBO9/kQA85NfL0s7S3LvISXcksfU12fxd8QNqviM2scpaC1+X2LGuCR8yDg9aANSE/Nzk1p2vI7VlWxzjkjArXswNucjPegCS4ui7YOQuMDFU3fIGB+dQwk+WAemeOc0+QgH26ZoATzRznjnHNIs29SynjPSoHb5iB83bimIx37f0oA07Vt74U4HvWmZdsQWMjArJR/L4AOalMxAwOuMUAXJ5SUGzp6Z6VUdwGIbn1FRyTHbndkVD5m7Azhh1oAtocKAmTnqKlhkAIG3jpz1qh5h2DJ79alWQKgJ7jr6UAXVdRIMvx9eKlE21W35I+vSsdrwbgABxxx3qUynYDg4NAGqJiV+Yjnrg1WurpE9xj1rNecrnaSPT3poiuJ13Ro79+nNAD3u97YC5UnJpn2rD7QMKeCMVLb6HqE7grAyg+vFbOneENTeVZXixF7mgDR0KVba03FyHc54HQV1eiahFNvtJOY5RlWbgE1zcmi6hboWe1Zhnqo6U1J5rGZJHVkcKCdw6UAdxPBFBp45+bf0AzxXG6vtjd92A38IPatS01oXNnI0p3OPvCuZ1u6V5/uEockEHvQBTeYRvlDjb6c4960NNkee5Ck5Zuv+FYStvkO4jb3yTW5oypG7PzvxkENnFAHfadM3n3FuG/d/ZgB6jHP+NYt5cM86RkD5eBz2zS+HJg/iJEeQkOTGD65XFYmpM8d/MmeEbaAfY96AO60NoppMHaSOOV612dncQWEcs86ny1TPAGAe1eZeEr1kkUSE/L3Ire8UXLnTTBE+VLZJBoAzbnWpLq6knfaRuPI9PSueuZhFdONp2thgcetPQsAobOD1x0zUl1EtxAu0HzE5XHf2oAbbTZLGMYI5xV+G5w3zg7Rz0/SsuDJOPYDjt9ashvLJDAjBx7mgDZhfewy24HOcHpUr42AnBA7Vm2zblJDDg444/GpDIcKpP4UAWwQSpAAI9ehqtdPvjcgZwKfG+Ny9R0/GoLkrtzwMCgDKZhvkycn07VWkkJxnOQOeO1OuWCz9Tgjv3NVJpeceox+NAFe6fAOSx4rJuZcliMZBq3cvwSD261k3JGDhvlHHFAFW6lbDcde4rKmlLNz16+9WJpPmPrjPWqEjZ9fWgDT8Laa+sa/Z2qqShcPJ7KD3r7C8KWX2WyiTAXaoHArxn4KeDpoVOp3ibZZx8ikchfevfrC3EMagelAGnDwKczYxzTB044FMkkCg5oAhvZwgJzXlfxS8VRaPo9ywf97gqi/3ia7LxBqkdrA7swwoOa+VPib4mbXdddIm3WsBwMd270AcxPcPNNLLKf3kjFmJ9TzTIm5H1qBjxjmnRHLjnrQBt2Q5zx0zWxBxGMBc/SsS1fDD8+K1ImGD3FACeWyDBGAOlV5mOWBz+FX5XGwZ61k3MxDEdBQBC7c9M0+3I3MSTjFVXcZqzZxvPIEiVnkboF/lQBOrZY4yx9c9ant45LllEMbSOOwGa7Xwv8P57nY2oEBWGdo4x+NepaF4PtrNFEMKpkZ+7zn60AeHw+GNTnC/uCoJ/iPP1rbsvh7fSjLzJnPQKTXusWgqqjC7f51ci0oo33MA+lAHgw+G1+D8k6nPTKYFQ3vw71WJVy8fr0Jr6Haw2gY6+tRSWm4Y9jQB83xfD7U3PyNEecYYHI96sP4C1SHAYpvxn61739iVTuGQe/rSyRJLHsnRT6HHNAHhWn+C2EyfamLAdq7Gw0GCOMARouOPu9q6y50tVV3UBj6LxUUUYB75HU4xQBmw6OmcBOV5BHet+ytoUhwVBB4+70qSFPMGUIx1OashOMMOTxxQAwWFs2FDIM8fMKztV8PWVzEwkEb5AzkAVqSKTgheR+FN8ksrYUZIOTQBwdz4PhtVlax24IGEbkH8a5fUNHuI22mzRlHq3UHrxXsEsClQMcH06flWHd2cbSsCoI7cUAeRufshInso07rnv+NaWj6hYz3cELQQhZB8xB5+ldxc6LBPHhkXvlSK57VPDcNrIJIUEcwGRsHP40ATeG7iwk8QQEW0YPmbgM8gCqGu3Wly6tcAQJlnLZV+vtVbUftGhP54g8xGGTID9wHrxXHam4N/IUGEPIHsRQB2tldWKKDsbaRz8/NdNYXFvd2Jh82I4OVBcAivIIVfzEJJA/Q10OkrliF6HqOhzQB195pDb3MRi25/vjpUT2yQhGZkXHo+cVl3CBInCEZAySeKzw0ikbjk5+U5oA1Llk+1SMDgMeopN7eYH6n17CoY3diCwXGcfpU4AZee3IHpQA+J9pO8EHIIyM8U9X8wjrj26/WqysWXBBJHB5x+NTwucBjxjj5u5PegC5wVBHzDuT39DVa6YbeR05yetIsny5GOnAx/ntUcylg2BgZ60AZN4xDb+571QmbMbEkgjuD1q/fk+WQTyOpz2rHlkyzDBwOFwaAIp3APQADjisi7dcEkmrt3KMNggmsa7kBGc9e1AFK4fByOnrXW/Czw0fEHiDzZY91pbHLA9Gb0rjLhsk9d31r6c+C2grp3hy1LJ++lHmSH1JoA9H0TTo7a1REQKAMdPatpEHHfHFJCoVQBUuPSgBrkBTmsXVr5YUO5hwK0ruULGRmvJ/it4kj0jRbiYyDeAQgzgknoKAOB+L/jbyw9hZSAzSAg4P3R714mnXJJ/PrSXt3Ne3UtxcuXlkbcSf5UxTQBJnJ71LEcEfXioFOR3qWI4YHmgDYtug6dPWtGAnaelZttgr0P1NaUAG3nk/WgBbmTkkN16c1mSgvhvyNSyZPHOT1pLeKSeVIoQXdjhRigB+j6Vcapfpb2qEknJOOgr3HwV4Ggs4oy0Ikmx8znqaZ8PPCy2kEeUBkIyz9zXsml2CRRr8ooAoaZoixRpkZIFb0VooQfKMircUYUCpNuOnSgCt5IwOMUhjAHvmrWPWo2FAFSSPjH4fWqc8I/r9a0WBK544qCUDHrQBkSx4DZBIx+VUWXJ+UfStS5HB+XgdSaoOhL4yMHr2oAzZ8o6jLfNwKztm1gQMljyvetiaM7juXgdcdTVQwKJtwQEkY47UAWLSNiob8CKuoq7j/kiq9s2Fweg4+tW0Kk7s8+1ADPL3kcA5Pp1qTyec4OSO/apFfcRsHIPFWA+1sNzQBnzQDZgrgVlSQgnleSec966FpQR8wBPYDmqM5UHLDvxxwKAMWSNFHIb8OKxbwrJcMeD25/lXR3bY3A8nt/9esp15H57h2oAxr+COe2Mc0eVwQB615r4h0lYJjLaxMUH3kH8NexSzq0YyoOPUc5rEniR7ldyRbSOcDOaAPLrKOOQgkY3Dr1rft7ZraPeqBifX0rZudFhW7FwkAGDllA4b6Cr9veWOQjxgNnngcUAcopkZ3Eny8En6VBNnK8HORXoupaXYzQie2QMMZ61y2qaYkcQZcZY8Y4oAzVIxycZ4+lBkCAnGT65pCBGcHJwMVQkbLHK4HvzigC3HcBvlZSSfeno5J27Qo9cdD6VQWZc4wAR0NWoJELDHBGKANGPBXJAGPzp0m0bh1HGBUMZUnO4e+Ka5BQcZPc4oAoXh+Vsf8A1xWPJA5DEZ65rUuCXb7oCg5JzVC8ugqsBxlc0AYt2SoYN1BrDuTz+Nad4/LZzg9PpWTO5J4zQA2xjNzqdrB1Mkyp+Ga+z/CFsIdPhRRxt/Kvjnw5hfEmmljn/SFz+dfZ3hdgbKPPXAoA6FMhRxTJnKg05TgDiorg5Vs0Ach4y8SwaPYS3FzKqKik8mvlD4g+L5fFGoAopSzjOUBPLH1Ne1/HvR9Q1PRUOmMDtk/fR5+8ntXzTPG8UpjkQo6nBU9qAIy2M9KcjggenpUQPP408d8UATqSQPUCpojyKrpnnrwKswrlhQBsW3+rX6VqW4+U4HvWdbKNg9celaUIO3IxQBlkt0zg16F8LNCW4u/ts6EqMqoI/WuBt08+4VAuNxABr6K+H2lLBYR7VwAABjvQB3fh/TlhhQgc4HQV08UYXtzVawiEcaqBgCtBaAAZxTiP8acM44xmkxkUANIqJu4qYio3GO1AFd+BVSdwF5PSrE7bRWXPKWJAAJxQAkr5TpxVORvlz2z27U93PABwMdKqPnkjJGcdaAEZgfuscjn61DMcKOOMdOtISwOAO/XrTZXGTnjaM0AMMgCZU8gcDOM0yC4dZijtkHp6k1VlmTnd27+tU3uk3bw/ynn6UAdKlwI+WbnsKa9xnDA8E8VnmQzwRSKMq3b1qBJGWQgr0OevagDXjuDlmH3SKSZl3EEA+oquhAHy9fSop3H8Wc9SDQBWuQS5+Y5PHSnWlml1Kq7do6HHeow8cq/LwfXFX9JfbOyD+EHv3oAg13TFjt1e3UcZB56VycsYZRkEjPXOCDXdpN5thMrEHad2frXNTWy7mKjk/oaAKkIRiu1SD05rkPGWzTJPOU4RjggevrXcQ7Yyw4LdvTNcd4/0yW+sd6KXcEZHfHcUAVNJ8VsjRxNmRCoG2p/G2o21tbWzRuTK4zt9B6150k/2W6VF/wBYp2MfT1p3iG9kuLpUkPKIB16GgDYttQRwvmMSCep6Zq7EFdAysMMTniuLR9gznJPXJ5rZsL50XbgnPqaANOdNsrbAASOnHTNOilKqQ33ScDNJHIXVTIAO2c+tTtApUEZYjk0ATW0oyCxwakdgVYgA9/xqhyigMDg+9PDjIHIIOD3zQBHdZBJGVx1PrXPXsm1wM5BNb1wVwcg4AwRn+dYGpjA3ZGM4zjpQBk3HJ45x3rPlyTmr0oIbJBwKqzrtGWHFAEdm5h1C0kXA2yof/Hq+zPCUxewhbII2jkfSvi8ggqV5KnI/Ovrj4e3Jm0m1dsElFPH0oA7+NuBj8aiuMlTjuKWMggY70SHrx+BoA5nWrFJ4HDDJwe1fLPxi0ZdM1uGSJMRyqcn0YHpX1zf5KMeR9a8f+I/h9dXQxEAuSTvA5BxxQB8y9PTGaeDjg4zU+pWclhezW06kSxOVbI6+9V8/NQBMjfrVuHk9cVUi5B4Oe1XIAN3NAGxY8k464rVjGAB0GO9ZVlgc1qxDuMnigC54Q0mW41uAGPKr8xHWvpjwjYslsoZdpxnA7V4x8MYS99NKcFcAdK+g9B/1CkDtQBrwLtAzVoHtzUa9KlHTFADhRnnNJ9aY3HSgBzEZPNU7y6WCPLHA7e9RX919mieRvuKCSRXht/8AFaz1LU5gJGihjcpHv74PWgD1y+1AFeOh9+lZsl0CxIK4xxz/ADrhYvGFrMvyzI/pg/rQPEsL/MHULk8HFAHbNdLk8/Nj/OKZJNhTyDivNdU8X29sSUcHH+1x+FY5+JVtJN5aIy46sTwaAPVhdfMTkj8aS5nUIc9hyM159aeKraXrKoJ75zmn3ni21ht2LzqB6k9TQBr65dlYSQwG3OM+teb6j4nnivWtPM4JHQ/nVDXfG32lnSBC69MtwPrXCSTTXV35jE+Yf4h2FAH0x4e1cNoNq7kPu7HqBWrJqdv5WVVlk6c14bonip4o47eQHZHwCDxW1d+KbcxbRN8xHPrQB7HYXsE5AD5fOcUy9dODnJrxDTvF1zDeebB90cZY5yK7e18SNeRqXwGIHNAHRvMwyAflU84NXtHnVJC0h4OeTXNR3aSEg7yx6HsKkN44GyNSCSMj3oA7KzmQtIoIKuuOlZczKrv3OcEAc+1RaZI3mKxJ3FexqGSVXlbOck5/GgC3bxB5TxuGeSf51Le2kZjfzVDDH3cd6hts71IYA9etWb4ie1dEBVz17mgDyXxNYabY3K3QUuwJZlXkCvN7+9F3M8qjAY8buteya/p0XkTB1J3grk9uK8RvLaS2upIZVOY228jFACiUueu7Aq9byttwCcZqtHEdwwMVZb5TgYHpgZoA0IrlwQA5A9639OuzJHsY9ec5rlYm5AOfcmtK2cqUboAaAOmkgMg3JwWHameSylge3t1pLC4RouTlh3I7VcdQyfL69aAMyYtggkZA61i3cZk3LzyPyro5BkOEwOxNZVxGuckZPpQBzUkTAYxnGAc/zqnOnHBBzW7cREbsHjGelZs8eM8HHTpjNAGTLHkEHg5619KfB/UUuPD9mM5bywhyehHFfOEqYbHB/Gu/+EPiQaVqDWNw2I5W3IffuKAPqaBuAOvv61O3I9qw9Iu/Og3kgHPFa4lBWgCtdKGRvTuetcT4iURMsgxkHJFdrdN8mRnB64rkPEQXy3Y8t0AoA+Y/itGF8SGZBw6AMR3IrjF4OfSvRfiXZkl5MFmDE59q88xigCWMcj0q7B2qmi8ir1spPSgDXslz2zWxEq4x0+lZNljIJz+FbcCg5xnpQB3XwuQky54+YAnFe+6ANtuobtXgPwvk23E0bAcsDgHqa990J90I5zQBujoKkH44NMTnipaAGe2eajk3A5xUpPrTHNAHjvxm8Ym00640bTo7k30ygNNGvyxL3yfpXzXc25aXPRhX2H4j0OK4vGuRGpd+DmuM1TwNpV+7faLVckZLINpB9aAPmEySwthHcduGpwvrnbgzy46feNe36n8ObBG2JDuAOdx5JFYFz4HtYmIEHGfpQB5UZpGbDuzd85qdG4Oe1dtd+CINxMayLjqQazZfCUmxlimIx03CgDBFyFYHcc02W9ZgP4sHvU99oN/bOfkVwDgFayZobiDPmROvpkUASvNllA5J4we1W4FEaDJILdT6VlBzwRjrzzWhHdxeUFdfn+tAGtYxAqrAHDNU88LGZ+OhwcVJbz20MUHlxs+ADy3FWZNQwoKRRgHkZFADLeIjHHCn04Ar0DSNP3xQMQwXGfr7+1eepqT7GxhSOOK7jwZ4id4Filcbx8vPpQB1qW0aAHB6HnqPpTY4MzlmwF7+lWE1CR0fCRkD0FY1zqkjSnbt2g8DuCKAOjjnS1QJnthiM8elOmfbcqyAFTzn1rIfU3KhgARx261PZ6osrhXUdskHvQBuQsFKjGQe2ehokba3POTzVaG8iIVShU55q8oimQncRgnt1oAp6lax3URCn/voCvIPH2gmPN5EMhfvgDBx617VHbuQyhlf0INc54i0oy2UqMBhxg9hn8aAPBoM4APTpUo65IIX1qaaNYriSLOUVyAc1KyfIV6/T1oAgiGF6ew71etsuepIHfNVVRhuLEE+wqVHOSo4xxx0zQBr28x3bVDcHjnr71tW7OYgOCw9a5vzgq8ZyasW98Q5AYHPQHJ5oA11c/MrdMnrVO5wcc89yBQ0jOnALMT6ioTcgFg5AIPQ0AVrqPkE4yRg8+nes6eNSrZGcnitG4YNk5UkdBmqEpLPkAk+w60AZc0YHXBA44FVH3RyqYyVdTlWHBU+ta8tu7AgxuQO+DWfNbSHP7s49cUAez/CnxlJeWhtr0gzxEKWz94etet2eoLIoI5z05r5c+H/AJ1vrgQggOPWvoDSmfyUIyQOw70AdTLMuCR074rntaUvC5C9a1YiSgGCB9KoXyFo2VRzyTzQB4v4+s/NtZQeoB5/pXi+zGR6HvX0J4wt/Njl+UZB9OteE38Bhvp48AbXPFAFdATxV63HTnpVeFSD04q3BHtctubnsTkD8KANWzwB7itiLAUZrGtF5Bzkdc1txqNqnGeKAN7wTdfZNaCk8PwOK+hvD825FYk884r5ldntJ4plyNjbsivd/Buri50+3kyCSoBA7GgD02FsgGp84FZdlcb06/hV9XyPagB/Yc1G3Wn5x9PamMeKAKlwgZTnpWHeW43sRnAOa3ZTwcVm3AznOCaAOeu4skg9c4yKx7yyDqQ6cdc9ea6eWME5bvxVK6jChsAnsPQUAcDfWjx5BUYPPpWb9kQlty9q7C+jSVWVsE9OlYkwMeQFJJPrQBgXOmI5yRhiPrmsq/0hHQZQY+nFdZLIAcgZ+veq6tlslQ3t2oA881HwjDIm7YIiwyCnrXHap4fu7SQjYZIgcbh2+te+QWkN4yqFA75P+FTXej2iRuqKruwKnjrQB8+MHWAeWTuA7dMVbsfMkj8uRlGD1Y13ev8Ahjy2aW2iKsAcoB94e1cDNE8c5UqQd2CKALjL5cbFlDEHHHem6df/AGO7VwDj+IZ7VBJKT8o5Vex4qlPL5bqSQSRigD1HSfEENzaGNDkgcsTyRViCRrmVlttzkDPuBXmfh5i0rCMkEngDtXo3h1XgDu33gpLDNAFy6nmtW2zIRtPrxSaZcSLfK2cBjySevpWpdKLvTo5mQEkbSe5I9ayrODBZ1HRuM/4UAdTBKu4so45zzWhHeuFJxz6ms6wThT69T0/KrcyopBUgMAOPXNAFyO4kLjB2j1FZGvSM0LiQnL+5qR5igG3rnGc84rF8TagtvAzMSwb1PGaAPLJcHU7nPTeeoqVXAyM8dPwqm5ZriTeFDFjmrAzwxHTpQBJIdqYyCT3pkRx14PsetJK33dwHHQVE74PYHGRzQBMZcnGce1KD0bqc1WEpcjPbvmh5c42k56Y9KANuzmI2qeh5x3qCaGR5SV3Y/nTbEsSXOMZHWtuEIYwwHOADj1oAgtLSGNQ0zKWboMdKskqWLIvA7etRiUKQQOevPTFQvMSThh3wKAFmkGSDtGBwKy7o7uPUZ9KtuSVJbBPpVCZc8sep4oAs6BObfVbVxnAYBueua990KUNaowHQDBHWvnizy13CEO0lxg5561754ZYi3RCBnABJoA7K1If7wB78CnXEWQSVB46UyzAAAXAOO9T3B+XHWgDh/EOnRTRvuXBOckCvn/xlpQttalCLgOAwwMZr6W1mMEZX8c14x8RbLZcQy7QMkjmgDzMWhUHA46mpYVGTnNa0cantweOKeLBS33dpoAitlyPXI6ZrXgT90Og/Gqsdm8RJ2/LWjbggYUdu9ADJj5kQduo689K7D4ba0LS5NlI+AcsmTn8K5mC23xHJzxkDpz71W2tbXCtG21lbcPrQB9OaZd7o1AroLaTdgV5D8PvFKX1uschAnXhlJr02zugR757UAbYPyg45qN29TUEcuRz2pGbNADZm+U1QnBIyKtSc4ycc1WuDg5B69KAKcmAMn8vSsu/lCk4PA9a0bjJGO/bNZN8ww2QCR3oAxLyQhyUOBnn2qjOqyZBKnH3eM1Z1DGXCEA44GKoRFIz8pOehA5oAqTIqEdiOKqS7dmTtBB6E9K0dR2lN42gAcg+tY5HmEHOAT0xnNAF3Trjbcoq9RwcdvrW5I3mHaADkcVztpkKH/jxwD3Fa9o7nrjsRQAl5amWH5Fx8uFHQ1xHinwwZYmuYEBlA+dcda9QaaIL5bAZxjnmqLoglJk5yMcjgCgDwWbTAiguuwg8Z4rIvFQOTjocdOK9J8f6O1tN58QzbvyQB90+teZ3bj5hgAg0AaPhuUR3BVEXk7iRycV6JoqO0N2205KY+bj0ry3R70W94hI4PHNeiadcv9llYM2GHHNAHTRkppi7U+USk5B9uadbtE7B1ZVb6ZB+lZkd4DZuCuAGyTnqcVHEwduAcLzigDrIkJjX5vunjB/WlmDBA2QQOB9PWqWj78E7iwPIA7D0rogitHtcqpPFAHNyztuA/untxmluLS31G1eC4XO707Yq3f2LxSnqQewqvABAW4PvzxkUAeZ+JdCOnXjfONrfdJ7VmxKq8F8/hXU+PLgzuJCoG1toAFcpAxYAZznkfSgB00QMoOMpjPPFVpEYglV68VpqpYcfh3pk0SxoNxwT1FAGKE/hJ4zn1xWnY2vyiSVc+gJqW1sgp86cY3H5U7E1ct42kbIwB0xnvQAsJ6gKoT+QzUyScEDAx096mZNickbfY/wBagj+ZmxlfQ0AMZ2K44A9fWpFG0chjnvihmCrk7QRx0qOSRuBlgM5NADZyMlicZGQTVKcDHuBxirM8iZH9RmqEtwpJZgVGcYFAFnSUDarbLxkyDivevD65ijYtjIOQetfPulys2p25QYYSA+9e6+HpnESblOO/1oA7y1BwMDA9c0kpdW+Y5A7YqKylJiXIIPb1qWeT5WGOvrQBm6hgxnp+FeTfE1l8mFCAfn4Ir1TUHAhLsdq+g714z8RroTXUMKnAGWNAHHIAGIUnj9Kv2bnAB6k8cVShUbhn8jWla7lIIOAO1AGrBACoBGSeeeeKlk005zEcE+3GKWybcR/jWzCysgyABjigDOaARKI+PQ4+nrWXdQHJJAznvXYNagscgED0rJvoRk7jjnvzQBz+m3M2nXonhOx1647j0r2jwh4gTULVMNiQD5gW5BryOaANkL8xFXtOll02ZZYpMPjn0oA+iLaQkAg5q6gJAzXnnhnxZBdxpHLKIpgPmQ/0ruLK7WSIHd749KALUg+WqdyG6jP0HerDyg9jyar3EgXt9BQBRnYDqOcd656/++SucGty4f5sAcmsfUFLRnA5oA528lUszOMoOgz3rGuZSm452Z4wTV/WZBAr7sBVGckdK42e+N5c/u9wH8IPI/KgDdjud56/L3GM5ps8TRMWjOM9s9feo7ZVjCjDb+vAyBV44KBdvT7vPWgCml0C2x1K5HXNatvKVMeG2swOMGsw24ecPGTjPQ881rxx7FUycYBAGPWgCV5DkE8k9/ep47hZEAfnH3vrVI5ZvlyNp6f/AFqXaQhGeOuBQBF4jKXFk8WFdWXaR6V4H4l097K/aPkpklT6179eq/lfMMcD6V554ytEmt2Xy1MpHUcYoA8vV44GTcMsDniu10TUluNOZ48hgBwK8/vreS0uHWUMDng+1b/hiZPIKN3PSgDv7bUkS0jiC8s3zEjjitG3wVJVsjsew561x5nxLliSD2zW5pV4SBEMA9sn9KAO80mTy4Vk34B6DscVakuiqZZvlHC4rlba9K4ReH55HGKtC8ZlODg8jnrQB0S3ZeMJjfzkE9jVPUW+T5ACw4rNhmcFduQMcnOM1Ff3bICWcjPG0DpQBj6/Yi4tZApJcAkcdcVw0QkhdgflPTGeldleX0rJIAoIxg4PSuAvZJhfyoig4JwTQBqx3EgIPGPr0rRtLUMjXU2NoHyDuxqjoVi0rl53GwcsR3HXArYmnHBDeWi9CeSfpQAxRHKHMnLAYA6D8B2ohKI7lgWbPC5+7UGd8rcA9hkVNFE5RmY44xkc0ATBjLngZ7DsBSLGBkx5DHg89KhtjtOxcHnjnqKs7irB2+UHAAPOcUAVrrhf8fWs26lKqDnBA5960LiUnlfmyOQR1rPutm18jJ96AKEk5x3GeM1VkycDPGaJ24GD0poVnKopzuIAGO5oA6nwLpj3eoi4KYjjPGe5r27RrMxxqFXK4xn0ri/BNillYRBscDB+vrXpOnqpjBVlH45oA1rSMIgptzIMnBIHT60+I/uuPpVS9ZQjZJC46etAGDrt55SMMAqB9a8O8S3xvNYnwRhTgV6j4quhBBIzHBCkgfhXi5kZ3ct94kkmgC3ESc9d3T2rStgox3wAoPIwKy7Z1GcZP4dK0rfk+wOaANizJGTg49+9a0EhCfeG7udtZVkcABenXjvWiGVMEDAxjBNAGzYz/aIVdxhgcN71lalBIyknOc9q0NKjdNwYkA+3SnSRlnDEce/egDnYY5RJjHOeeKuraOIycY3e3H1FayRBSDxnPFSSxArjcMNQBzgieEqV3Z7AetbuleKdQ0370vmx/wBw/wCNRTW6pyRx6n0qpNGMBFQZI79s0Adzp/xDglfbdwvGx6svIq5feN9OZQsdwu772G4NeZRRKs2GA6Z9M+9czq58ydtoJJOeOwoA9pj1sSZkEny9uelNvNbSGIOeCQRlq8Om1O6trcLBcOi542npism/16/mjaOS5cr04NAHo/iLWI9SlKRkn1x3pNNsXhQTPlWI3DPUD3rivBDmXVP3zlolGck969SfbPHhACPfofwoArxLnAXjtz/SpFVmcIoGQeCO9LOq26FjkAe1UoL7bKBuBGe5oA0wiJOsjP8AJkEqBg5q8zecMnjHHBqnFsniUMAJFOcDnAq6u1RhT+OOtADlt8Ekbs+54qRWEYJbbUSXAWMfNyPvGnu0bjAwT2xQA4nzojuHPQDr+Nc3rOlxTl3ZiGI9K3iRGwQFlzx1zS3NqszcFs9OB0+ooA8a8W+HQ1uWibdIOeK5HQBKlwyJv3ZxivcNY0cvEwBPU8dTXnN/pj6TfrMif687SQfu0AVgsgf5weOOTWppSTPMGjGNvJJPH0piRCZiXOBk4FXrVPKX5UIJwcep+tAG3b27RkuTySCD6H1q8uza2Mk8j2+tZ1g8gwrbiRwe+c9PwrZgtHc7iuAw6Z4/L1oAhUkEEjdgZ9OR/SqNxGLuUqgJc5x82K6FrQbVbAySdwJ/pVF7YRSl1ZSp5Ix+lAGFBZblzPhVySBXN63HGdXaKIBIwoLNjpXVauWigd04c5IGODXG3twJLxnCEcbcMc9vXv8AWgC5LMkEXlRkc8dM4H1qqXJYrnrwAaqm4LFmdjuz0I/CnbzgZGAB3oAvwHeCGPzdj7Vft5SyOm47tucYrLt1JbLEYb7uRWnpsBkaRxwoUg4PpQBHFncMYbnjiiVg3HIwe46VOqJ5iKS3496ZKrZzt79T/KgCjuK5DEeq81nXjlVOCcnpz0q9cEb+Bk5Izjisq87sCB2oAos+ep4POa6TwTY/atRErrujjOD9fauWXJJ5GT054r13wLpvk2MYI+Y/MeO5oA6vSrBJAhBbap5GeTXXaZCUyDhUHAH9azNLiWIgDA4wB7VuK5C9CAB360AWZG2LkL/9asvUZg6ZBwOnNWpZiTyT9a53V7tY1kB6DNAHAfEDUfKtZIgcO/yjHavNo2O/PJz61qeLdRN/qrru/doT3zzWXb8kd/pQBoWylcYx68Vo26MWBOTnsKpWik4znArdtIRhQ2RxigCzYq3lggcDnpyavICzDeTnHriorRdi4PGBzurQXYcHjp0NAHTxQEynC8jnFNktjv3EAgcn2rfezWENt5Y+npVG4jGNvQk8dRQBkGDBycjPpUsUW0Y2gDHU9Pwq5HGFbBPPfipHiVhtQBvegDIvLf5A+M46ccVm3S7E3OM84xXQyD90ccc5AB4rNvk3sqHj120Ac7dSCztHwfnk6ZHIrmL+MxxtuwWb0rotaUvMihconJ+tc3ckbm8w5J4IHr70AYt8+VUdeOTWPdR5BJHPrWzqIXOAPYDPSsS4fDEKBk0AXNA1AWF6CxG1xtyO1esaXek2QYMGPBJ9q8UdMnkHnncK6HS/EjWtssE6kqOkmeQKAPRL29aRiA4IPJFQ2yvJMCVUqByccmszwrbXeuThoEbyj1kcYr0ay8OrFtZ3bpyAOtAGSk3kwq+AGYZDY7isqXVyJWVXOOvv9K7K40aIooZWIGT1rnNQ0S2OcRsGIz70AZy6i5fgBsk8n0NXobrYFJc7twOO1RwaXAHJdWx1IHarcumJJ8yMwA5wRQA+K/jkYbSR65rZilJiU54Jz15Nc7HYNgkSYyRgd8VuxwtHGACcDue1ADboocgr7n8f8iuT13T47hVQL1PbtXXMuRlh94cc1n3dv5kuQp2hd3sTQB5nOHivJYH+8G29MfjWnZHzHAKjJxnvVjW7HJWbOG+6x7/jTIY/LXdt+UjkHrQBradHskB2EMBjjgV0FshC8k9ckj0rA08nzB8wGP4eoroJZViiLAcNg8UATTKzBsgHuay5W2NiN1yOeRSXFyzgBzgZBGOtOt8SFuApHynvmgCjc26yCa5UrmMZx2JrzO7mD3TE4+8cgjivW70FbZlVOCOnevOPEWlMjPPbhio+8uKAMQPnd39D3/8A1VYjVWVepbsfaqSZC7dvU5zVuBjHySeOOKANezT5SMrjGRxz+dbWnr5nmBB1XJA7+9YNq2Qcg9cjJ6CtywuURxv7Aj60AU3zDIy9S3IOMYqS4KvAjFeR79afcujAfNkgemaiuWItUBIKkZOOMCgDEvJMOxydmcVlSuckdUz0q1ecZy3XJxVG2je4mWOEbnb7o6ZoA0PDmlPqOqRooHlqwLN2x6V7rolkYUQBSAAAcdq5rwPoKWltHkDc3LH14616NYW6oqgKD6k0AT2sAQfMBggdOoqZwyhgev8AOrMZKthlXHtUF0cK2APz60AZl3KUU4J6d+a888d60LWzk+chyCF9zXX6/eiCNiTwO5OOK8J8Xam2o6i2x2MMfAPqaAMy0BuLyFHJ/eOFLd+TXWeOdBg8MeM9S0i1mlmhtWCo8mNxBVTzgY71zOkDOoWhx/y1Xn8RXoXxlXPxV17Odvmp0/65pQBzenRrwzHn0NbUB+Q8KB3wetZNoByFUEdq1YFIbd+YHQ0Aa0EOfmxwDj2zVkROVyOD0OTxn2qtE5KAKf8A69SQszbwSOvJNAHq0qO5+U9unes64iLN82cE9BW6UYAA5459KpXQAXL4+goAxihwGXggcDHWopVZemGxzVqUDblsbs44PSoyhILMCWzjmgCjOjY+VsHPp+tVBHulIXluuTWjKpJJxioYkUFpCeADzjv9KAOL1GMvJctjocfXB5rmZ4WMm7bz2AHSuuu+siOP4mHPUZrnbxdwKpnrj/GgDmb9Q27jCnvjpWQYgynp+HBrobqF5MqcgDgVk3UQt1wijLdSOTmgCjJCzFY4lLO3AGea7Hwx4OJZJ735887OwPv61reCvC7Dbc3SjznGQp/hFej2liFYKik4OP06UAReHbVLUqsQCLt2kAcV1cMfmIM9D7VkxRxxL9zJHX61bS5YIScjt7UAS3aqCBjJrIlhUuduSTwe+Kv4O9fvEHrTpIwDwOe5H9aAMlLEEK2BkH7vf60yS3dAwbPXuK1UhG3BOW96sxBWwkqAqRwfSgDlzbguW2nHJx6n0pysSoGT0x0rensVA/dtk9g1Y80LRBgRyDj60AV33DB7464xUUy7bV3Y9egxVhstkHdngUXyFYtpIDY+tAHL3MCyLJExJUjHpWDaElfLY5bkEkZrqgAk2CDyc81zWpYh1O5SIAhW7+/NAFu2xCR8rEnj2HvVtb2R1aMqo9DjtVG3ceVjvx19PSpQD5oYkKRj8qALKguyh+VPQVp28YVPlXkDJzx/kVFbquVGOCu4+9XYYTnjOcgY9R9aAHPGrRBGj3E9DjB/OsbUbX92xZMAnjPQiuiRAVOcYPf1qveQhlI7Dnb1oA8n8RWC2jLKhKrIfun19PpWNGxJLc4PTHau48X6ahtWZCwbOdhbr/kVwJkCHavA646UAattOMkAjdnp2rQhuC8xLkng9u9c8rghTg5HJzxxWhDPmYLn5yuOtAGn5u+HOQG6cmo3nP2T5sEE/wCRVMzYQpk5HIB7UpkMkOd2c9BQBQvGw7cHGc1oeDtP+06oHIPlp396zLpvmOc7c8DNdn4JiEUMZYdW3H1FAHqWhxhUTAwBxz2rqbNP3fUexArmtJ+ZlCgfN0xXSxDYMHr+VAFk4XpwT71n6lMsaMxxwQRVuaQbTyD6153498SRabaSM0mXONqA9TQByPxJ8RlJjZ2r/Ow+Zh2FecR/MPlOfem3t3JfXklxKSXkO40seA2Dnj0oA09HUDUbbGP9avH416D8Y+Pidr5OOJUx/wB+0rlfB+g6nrV2raRp11eC3eMymGMtsBPGcdOh/Ku/+MehapF451zVJrG4j0yWWMJctGdjHYo4PTsfyoA4W2K/QA5wDWlAw2jGRnis63QAckfgeDWnCu1FYgbD174oA07ZsjHDccGtBVUqVYA4P8I5rMtyAwwCRnPr/kVdO5hlQMnqO9AHs06NuUggD+IetZcxUs+WBPIBUcfrU11MZJELswXt71QmkzK2MAgZ/wDr0ANlti5U4Jx04602S3+U4XAJxWhGHeOJh19v60rx4XB579KAMG4iI3HaTxjjtzUIXa4CbgcHHrWtMhBOFA/CqDRbpBkAcZ47UAcbr9uYr6QD7rDg4zk1hXEQUnIwo6Aj9a7jxPYOI4peGReSM4Nc7eQs9qvlqQM7ckc8c0AcneOohbYoDBecetQeF9N/tDXYvOXEUfzsD3NXLqEpEepJzxWz8PLYvcsXX5ZPzNAHoWnWgWMYGD04HGK1DEN5Izgf5xVi1hRFHyjjj6U8oQCwG0E9xQBTkgQ7VbGB2xzSCIA5XpnJq6EDDkYx3PSq8xIyFwBj8TQBEAGkGDyO+aezfMTnOP1qFuwyemOtIM4PNAEzFR0GQOc0Agjr9abGGIxg88HNTBcn5iR2NAEbHJ4JNNaMNnKhl4qV48DJHIOKeAzKqjpnBoAy2t9j5HT0qvqIBhkbr82Mk9a3AowOPm7GqWq2ha1LJ1zkigDznWZ2TkttKnPHcVzK3gub6ZmwdzfkBW34pcQrMSCNvp/jXn3h+eSW9lLELubIzzjmgDuoIisysMnnIPtWzFaCUI7YHas+zeFoEyN23gba1bSUHpz3yaAL1rbiHIcqQfTtV1FHGEwD1xzVaAB+UHTrjv71pQx9DnDAZoAjkzkHA3DnntzUc6FwpB4GcjFXPLw+105647UrKQcYwev19qAOQ1+IyQ4YZBJIBHNeS6tH9mvpEYHrkeuK96vrETKQfvDJHHSvKPHeg3cNyk6R7wchivrQByIkIHPK1ctJN0oJ29PxzWZLvQlWVlboQamtnx85HOOaANQOCSHOfXHap7bP2UhjkZI96yhKQWyeT6VrWBElnuzuAPzA0AUbhF4I7mvQvDCJHFGQqlSA3HWvPZiRuTqp4xmuz8J3OxY2GSmMFccYoA9S0YtxtJXAzjHSugS4ADA5OTxnpXMaXceXgkk55GDSveMsjE4wMkDOKANHXtUWys5Z5WCxxqWJ+lfN/iXW5dZ1OS4mOFziNfau3+KPiEyQJp0UuQ3zPg9R715eW/eHnJPTFAE8ZAxzj3qzEoLA9fpVaEM5xzWnbRFgCDhqAPXP2aNWNh4+ksWY+VqFu0eD03r86/oGH41337Smq7bbR9IVwPMdrmQfQbV/m/5V4R4PvzoniPS9TjYD7LcJKcfxAEbh+IyPxru/jLqy6r8Qr542Dw2yrbRN1HyjLf8AjxagDirdsMu4YxzkDrWpCRsUj5v9o+lZasobnHtnpWjakYLN0PC7uMGgDShjwRtHOM4B/StGGMNGGJ445qCwj8wglsKOvFWJJEGCrcDjaR0oA9Fv5CFHXjkfSq0UO6Qvn5TgHNWJo3uJChXCg5/KpoowZNuAQemKAL9tH+5BwMA46U/Zx79KvRWxa2UbsZ5pZIwAwAyx6UAYc0JVTyOfz+tZt2DHhVXLDpj+VblxCFGZCTznArLvJAjfIABg8gZoAzri2FxbGORnDkEDPQfjXI3UnkTG3myo5zz29frXRXdw4Zcuw/3fWsjXkklh8+M4Zfb86AOH1xgucLhs8Ed67TwNAP7MtpMASbOpGM81w+pl5yVdR5idQB2ru/AjCXQICi7nRihB7c0Ad3FMRGFA69yKmDAoOeMdqit2zENw2t3WpcYHQfgaAIJ2bbxwvTFVpF29CCasuMgj0OQB1qtLnPueOOlAEWMkBeqikKk7gc49KnijG0kjk9+1LsBHBA+nWgBIW2A9euMdqllJyc+nrUW3pg/gacM8F+e9AEeeQWPFPj++Cv3e1IApYsQeD0HpTlwjDOMHpg0ATqpCjIANPuA2AuFI7iiMgkc4p1ywAJ2kj0oA8L+NZOlQRtFkC6baODgEda8fs7t4JkcMRt6n1r6C+K2ktrGkTLglk5jX+6RXzk2UZkdTuU4PtigD1nw7dCS3jfPGB82a6G3ugJGCAsO3HSvLfCWpMkohduewrvtInMhTceTjvxQB2umOygZTcc8muhgKyK3QORxj1rnbTGwYYcADnjNakL4Ckk49qANHblRkHOQBzUwgPXqo9fSmQYIDOpUjr71ejXfjuOnFAFTyF3kZzjrjvWfrOmC8iKlOvQjrmulhi5HGDj0qXyFIB6nFAHi/iTwUs8bsEIkVT8yjmvMNRsJ9Nl8qbpnAbswr6xmsEeNhJypHOe1ebeOvA4v4mFo6rIeV3DOKAPDTIdpbp6VpafIBYv61s3XgHU1RQjIT3wKranol/p1uiTQMBnlgMigDHeTB4I69TWpoGq/ZZBG5G0/d+tYk/LDGDjk1EjHPPAHNAHuulXjPZIylCAvHvWPqepMsjOoGwck1xugeKpbG2jWfDwodrAddpp/ifUCt1dR28pa3ZVMYHTBGc0Acvq96b3UZ7h24LfKPQdqpRAnn04pCpc8dvepYlyTknI7UAW7b7w65HPSta2haZ8RqST6Ck8PaPdatepBZoXY/ePYCvd/CHge00+3TegeYjJdu5xQB5bp/hrU7kLiIqjcjIrXk8KavEDI0fmEn1yTXu1ppcCAKoUHtxV02SEYCjFAHzO9pJBNi4jMTjnDCtCzjLAYAycdW7e1exeJvDFrewsCgRz90qOc15g+lzWV80Myk+WcqfUelAFoMsUaqoyx5PPSqck+1vY9MiqmpXqwKVDAOSCcGsGe7eSRg5IA9aAPoq+YjmIYYd/U+lGmnfcBkAZm6gU6W1MibDu68e5rW8Paa1uwmk4A6UAaXklogCMcVDMu0cLj+laZAI4xmoZYyVJ6H1xQBzt0mWwxOf5Vmy2uSzEc9q2bxHUln3ZPcVUKlmOTkEdxQByWp26hm8sHPXJ6Cucv2dGYbjno2P89a7i/tjIp2jIPp/hXLavp0ygNtbB7Y6n1FAHBavCIroS+W2CCCR1/OtL4f3/2S/mt5DhJOYyx5z6VqzWStp5jnCYYEAHsccV528ktnexJGP3kb7iV9BQB9E2UvnDbwcDB4q0F2r8hH19K43wd4hgvrZSJFZsANjjB9DXV/alwQpHPIyaAGTxsRlKgjXcw7kc4zRdSnkMWyenPFFrF8mRg5OTQBI2C4wfekVBn5Bz61Iqb2GMjH61OVC8D06UAVtgUgdPSmkKwJBxjj8albv6GosfJwMH0oAbgbQMYz607apPYUxlwAaFODg9f1oAuLsCdenanGNZF2n6iq0TEgcYPfirkfOAMfUUAc5rti8QzIAVbjO3ivl/4j6QdH8STpjbHcDzo8Dt3r7NWNZE2OqsG/vCvn/wDaP8NNaW2nanCGa0SRonfH+r3cgH2yOPrQB4daztDPHIvVTkV6r4TvVljVwcgjBPpXkYfBBAJroPC2s/ZLlYmBCE8c96APe9PnyqrycY5x/Wty2jJkVuTgcZ/rXE6HqMNxEpVwCeRXbaUd6AnJJ9e3NAGxCpVgOCOn1q/EuBnOP1qGHGBznnqauRKFGPTjr2oAnQfNx+tShc9yQaaoHI5IPfPQ1IuSCWNACScq2FPTjNZ9xEshUkZ9PrWkMfxE/nVcoFBABNAGOdPRstgEcjnvUF3oqXCPvRR8vcVuxpuYccn3qZlAyM8YNAHz/wCPvB/2VJLi2jKMBnCjAP8A9evMicZ29zkZr661TTIr+zkgnRWVwQfX6180+PPDNz4c1WYSIWtWbMUo6YPY0AczGxJI9R0Pap5ZmdIlJyAu3NUixVsE1YmYbEAOMjPPagBjDap9cdq09FsJtSvY7eBcyOefYetZcZzIFIJJ7DvXqPw80z7Kyuyhp3HJPYUAepeA/DltpWnxrEuX43Sdya7mJVTGDgDtXP6dcGKNAMBccitRbokA4Gc460AbELrgdOlTKRjJ/irFjul+uSatwXW5hyeOeKAJ51zkEe3SvP8A4j2ywaXJdQg+cg/h6kV3NzcBVLlvm964fxxdLLYSL2Kn8aAPDp7p5XLORn+lV97HJBIzzimX7bLuReOvHFRlwPU+mKAPsuBF3bmUHjjI6VcR+cDAA5wKrhlEa5IDHgYPNKsnzFx1HB9qALpPAxSsNyHFMikRxgkg+9Sfc68qe9AGddRllwc+nSqghYJzwO9bLrn5cdarmDzJEAHfJNAHO65qNjodr9qvFXJ+6ueteZ6t8Skv2aCaw8iBjhZs5IHuKd8TL9tS8RTxsf8ARrf92i9jg8mvNtTj3Oygg4HPtQBtajqk5uRuYmMN0B4+tcr4huEkvGaJzh8gEHpUM2oT2ygZ3Dtmsa7u3lm85iMjOAO1AF7SNaudBvVlhdmQ/fQn73Ney+GvF1pqsKNFKCRwQx5FfP8ANdI5O7O761VtNVuNNuPPtHKydCB0NAH1c9yJAcONvXpWrAQFQLySO1eD+F/HyXflxXDbZRjIz1r2DRbsXXlPG+Ux0oA6a2QAFvwpj/L2OBzVq3UrCGOKgm6YzwaAKjk89SOwqLK9z+FPfIB6jHvULttHIH0zQArN8vH0xTTjf0BPrTS4HPUe9NDHIHXFAFpTkgnvVmIjp3qgrkD5Tg1YhbI5H4etAGxByPQVmeL9LttZ0W5069RXt7lSjAjpxwfw61dtmJAxU+oQmeBlQ/NQB8G63pcuia1faZcYMtrM0ROOuOh/Ec1SBIII69jXf/Ha3Fv8R7ohdrTW8UjAf3sFf6V5/QB2/hDWSrKknUHGc17P4b1Lci5OSR1r5ssJvIuFcZA74r1fwhqp8kBZCMjFAHu9ncJJEA5+mRWnFwMMQeO1cdoN8JYow2PrXW27DahzkHsTQBcjP5j0qRQcknB5pqY42jtUyr0HHPJ9qAGHJBJP4UwqCTjOOn1q20ewDoRURT2/XNAEUYxkHHpmm9OvQVKBjGQB2xmmsgBPX6+lAETDLZ6YrlfGGkQ6lZzQzIHVh0I6cda6thjp1xVK9AKEDnHrxmgD5G17S5tG1ae0uh80bHB9R2xVbCtEgbIYcGvTvjXpyJPp92FwWLRNxye9eZQRvNciOJSzscYxQBq6LAslwnlwl36ZPavWPDEHkICQxJ657VheG9ESxgjLgeYR8x967TTkKyL5md3T8KAOis5QsYBzkY471b8xzjBOOtLp0CHaNxGf1rZttPTI3YPtjgUAULJZJHxg7c8H0rpbOPaigDHH50yC1VMAYwPStCGJQoPHFAFW+sluImBARscEc15L45EtrNJBOCD146Eete2FAR6V598W9MFx4emuo8edbLv/AN5e4oA+btYIN8WVhxziqfmZ45z14NR3lxvuXcHKZwPaoPMzndxQB9ptcl5F2ABcjtU6yBpdx6MeB0rNiYAFcgEgY3HgD2qwX/ekDlkABHvQBoG4YYOenJArSikEkRHU1hvIQAcHGc5qzaXDbsnGCe1AGuoLKp7jrRKvlxSsOoU062OOc5BqzNHuglHX5Dz+FAHzXqsRk1Cd253SMeD71yepoEJAwDnv3rtdSRhJIcj7x6/WuS1eMbWO35unFAHE6gdzA4xnsKypiAjben1rV1ElZWB79qxrg9QMqB6jmgDOuD8pK1Tc7k9/Srk/K4OePWqrLtGAOKAKpYo24EgjgEda9s+FHiWaWzhhupGwo27x6j1rxaQZG7t7Vv8AgPVfsGspC5PlTNj6NQB9m2Dh7GIlt3yjmo5iCeao+GbtbvR7Z1xyg5q5d8defWgCnMSMqcAdKpzHf3OB0qdyG6cY45qs+ccetAAzDNN3Z4496hPPIYFfalyAASf1oAtq3bj61YWTAx0+lZ0cmRgA4qcPjpQBtW7c9eK0oSGHXPtWHauF6dMc81p28gJzmgDxv9ojwKdat/7e0yMnULOLbKg/5bRDnH1HOPyr5mU7lBHQ19+3UQnBDAEH16V8cfF/wwPCvje6t4V22V3/AKTbjsob7y/gf0xQBxi9+Mnt14rc8O6pJazqjsPLJ4rCU9M/lT48bhjjHpQB754X1gEqN5I7e/0r0jTL8MiMMkEd+1fLmi69PYOhOWT+Vey+EfEUVzZRyCQ5xyPegD1qO8dQAFzGeCc9K1bWZcBgM/U1xNpqoliABz3ya2LXU1VPmIA6DNAHTiVMc04KG+YEj6Vhw6gsi8cc4BPetPTrlZ9w3An60ATHkn+lRONrEjIqw5AVgCOnpULkE8cE0AVJH+YjjJ6GqV4dow3HOcVZvpI0jwxJ+g5rC1C8DDbnI4JYUAcD8U7cajFbxMRhXLKccj3rmfC2ixpfRHYu/dk5/wDr12GtCO9vXIbciHGD/nrUGnxbL2N0IxnBGOQaAOgOnheEA4wOKlitHSQ9B3x1zWvbRKyKSPlx+NWBByQvHHUCgB+lxZQYByvvW9bOVPzcEe9Z9kgU9wR3rSCBvlwOeaAL0DbgSelXIs8/3SKpRKVHXp2q5DwOepoAtL09RXPeLYY59NuYJPuSIy4x2IrdD474xXP+IZN9vLk884z6UAfGN2xjuJ4AeI5GX8iRVd3JGAcn3NP1d1/ta/C/d+0Pg/iaqr0BBP4UAfaNnKjNGHGGxgd6to4aUFWBKnv3qOaxaE7kU7c9RSxJhht5Yfw+tAGhIiGJOCGbtSRZV1yOvAqLzCGAkIDLxntmgzFMgZI/hJ70AdDZOMBSRkVswgMmCO2K4q2vHSYKTx1PFddpcwlhABzigDwPxbCLXVb2FeNsrGuC1h3CZZc46mvXPidZGDXJ5VU4k5JAryTXFwWBbHHcUAcVfgHcxHXoKxLhAu4Z6mtjUCSDncSO5rHl5Unkt2zQBRlGOOeneqbfdxnk1cuB83XmqkhC9BxQBA4whB7dKp7mSQOhIcHKkdjV1iDG+Kot1oA+jvgv40jvtJ+xTuBdxHhSeTXqpvEdAcHkZyK+KNG1O40fUI7y0dkkQjOO4r6y+Hd5LrXhy01K4jZPOTein09aANxsk5YfN7VCzEg5/L1q7Oc54qgxzIfagCF/lGOigcDsKjZsng4A6ZpZGxkHHPpVeQ7gQTxQBY3gEdMkd6kSTkHniqYO7rn0p8bYYc89KANq3lAGDxj9a1LeTO3HesKBiDkZ57+9alrITz/nFAGxGN3HbvXh37UejJP4e0/VlTEtnceW/wDuOMfzA/OvcLUEjBPPpXJfGbSk1P4beIImXeyWrToP9pPmH8qAPiwYB+bP50oz7ZpEOVB9RTguaAJ1GAD0Jrf8MaybK4CyH5G6c9K54A5CnpSkEDjrnNAHu+g60jbf3pOe26uyt75ZioVueBgivmew1e7siPKkJUfwmvQfCfjJJLtEnfaXwBnoT6UAe1xvjJBxj171c0C4kOpgAk7ge/Arn7HUYbiKQiRegznt710PhFhPqiqy5CqaANK9uJopPkzWJf8AiG5tFxIinA5wea7O4sVklLY5I64rltX0QHLScjoPU0ActfeJQ9wYy+ZDghScZqC41kyWvlwrmTOAT0qHVNGt2ulWRV3Z4OeRWfNB5c3lhjsTjAPWgC/ZjLhiAu7gnHWteOwUOGHUngqKwtMDMYkH3VPTpj8O9dzp0QMSErhSOeKANDToyYlz1xitAQhsHGM8E9qdZx5jTaAQOmRzV6KIkfMMA0AQW8QVuavxoDgke4NMSIhxkcdzVuNdwUYP1FACohOCMEVK+AS2O/OKRvlXAz7ZoZht5OCfXmgBHcKuWPWvOvin4otNC0C5leQecylYkzyW7Vt+L/EMOj2E80rqqICck4zXyV4y8R3PibWHuZ2bygf3adgP8aAMYszyPI5+dzub6k09Ae3HFRL6c1LGRnpn8aAPtCy8RMNsVwuc56j0ratvst8fMhkKSEcAmuYghW4iBkQMCeT3/CrMEMsR3WxchR909aANq8tjGAki4AGN4PB/CqoSRI8SAkD7rCtKxvluFENyuR056g1aurYiJgoLRsfyoA55CXJ6/J+orpdAm2ypkkKw7msRoWifhQBnrVuzYxSAA55wCe1AFb4q2e+2iuAueMH6189+IHLSMGAB96+qfE9qt7obhgCQuR9cV80+JLMw3kqSdcnigDzvUFO5iMDPpWBMMMwH511OrRjezHBzycVzc64YDj6elAGZc5Dk+tUpsgGr12Ah981nztgNQBC/3CaqnqcVZf8A1fPeqzYCZ7AUAdX8MPCcnjDxXBZsp+wwES3Tf7AP3fxr7DtrOKztkhiAVFUKABgDA6VwvwB8GN4f8Irc3Sbb+/Inkz1UEfKv4D+demXMORxQBh3AzuC9az5FwDkgdq2ZouSQOnGaoyw4ycc0AZkytkYOcnvVVgckHnJyKvyxY55/Gq7Id+WAH9KAKzetCt83FSNHyAKVIfmznBoAuW+MA/iK1LTs2ORxWbBGf6da0bXOcLjB65FAGzZ/eG3k8dfTvUmuWy3Wj3sBGRJA6cjPVSKSwTgZPIrV8ndEfoaAPzojyEAYcjj8qkUfN0p96uy9ul/uzOP/AB40kRySM0AOVjnpxTyCajRSTgYp4+9g9qAHf0qW3+VwwOGGCD3FNRc9eMVZhUcevvQB1+i+LZrRAk4LY4BFe3fBXWItShvbp8rjCKzdDXzfbwNLIqRgl2OBxX034H8PpoPgaDzV2yTLuI6E0Ad9dapBEg+cEnp7iuX1rxFahJB5qhlGTzXl3iLWpo7pxHNICOFAPC1x1zPJdEiWdgXxhsnigDr/ABN4oiMoFsd77uCM9M9atWcxlLM4ySOvqDXBXUMSuFgkZscsSOMmtSz1MwSIkiSSR8DJOMn6UAek2mnYwwGe5AHSuv0Mlo1U/wAPTI7VyuhamlzbKqQsuSOT3rdhuxAAduB1GDzQB2VlEDgr9cVpIgJ6Z9axNH1CObHynI/WuhgdWGV6Y9OtABHDjGafKNoAHAqwihiCeorO164+ywNIxwqjOT2oAr3l0qvgH5l96wNd8R2enWkk09wsaoCcseleb+MfH0doZCN568ivEvFHiq+8Qzf6RIRB2Qd/rQBsfEzxtL4o1AxWzsLGPoP759a4knPPf24pyr3P5UMnTPrQAingZ5x2qZRwAf5VHtPT2qVQSBjP4UAfYdm0YKbz0Bx9a1IOQCnXOc+lc7pkqzEZYc9j6+1dNYjAHGCB0zQBZaAyYkT5XHPA61Pbag6b8jI9KngQFsHpVK6iWKcscgGgDZQQ3MYDjaSOo/z1qs1jLG2Q29c5yDVW3maIAAbk69a2LF1LdcqaANMJ5umbCM5TBrwb4k6c9rfu2OD047V9BRLtjC15z8UdMM1g0qKCV+960AfNOp2zGQsxwuOw4zWVYacs93MXJJGBiuy1awMeQVJA+bAFclcyta3IkiYK+fm96AM3XrOEwyvGMMnXtXHTKRIeOorrNUuZruMhlVEznC96525XBoAp7DsHfNdv8G/Bb+LvGKJJEX0+xAmn/usc/Kv4nn8K47I8sEjoM19sfAPwJ/wiXgO0+1RbdSvgLq5yOVZhwv4LgfnQB1sNmsNuiAYwBwOKrXEJIPNdFNbccVTltzk8cUActNC2TwOPaqctud2eTXVPae1U5LI56fjQBy0kBwcDjr1qlJbkkkqePXvXVzWJ54qm9k3ORQBzbQNjOOntThEQen51uGxbPA6dKaLAhRuGTnrQBmwQ4I46Vo28PKjofSrMVmcj5TV+G0ORxQA+xj24P862ok3ACq9pb7eorThixg4oA/OPxPb/AGXxTrdt2hv54/ykIqjG5CbecZzjPGfWuq+LtgdO+KPiy3II26jJJ+DncP51yR46UASRMA2fSpCSXLAVHH19c1Mi5cD14oAsQgEEknB6Vbt0y/JNMjiIx+hrc0bTWu7hVVTz1xQB2Xwk8LPrOvwySIWhhYE/WvY/iTqS2sQs4jtjhTahBxk+1T/C3RhomjySsihgm4kLXEeK7s3uozsuHDOevO0d6AOG1KMzuSDg4wcDmqKW00SnCAqfunvXW2+mExkgZY87sZFV7zTZZgBAH8xCVCgYGaAOcs4WdGAUEbuWPX8KnSOQygKBlQeG55rstF8H3t2G34hjI5yOa24vD2maU7PM6TuOCOtAGH4Yea28xJ8GIgBWHb6/413CWjSRrtxg8VkXE1nCsYtVVcDJLjPH0qe2vo49oSRl9+3NAG3pZa0lC/M2TgnPH+cV1un6jGQEDDA7A1w8UrXO3ZOpJ45P+eaoXaarC4MLYJORhTgigD2GG8hKbg4K+teUfGPxzDpmmzW0TeZKx2qAelOsbjVJNNmjujIp2nDcjGBXhfi+WW/STfuLxOeW6kd6AOT1jUrjU5S8znHUCqsakgVKiZXr2oh9B+dADlQE4Iz/AEqQRhh0zjp704KOOmKeMAfSgCEjnAJ5piY5659qmflSMZqA4yOOKAP/2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Small bowel is trapped in the hernia sac (arrow), which arises along the left semilunar line.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Eisenberg, RL. Clinical Imaging: An Atlas of Differential Diagnosis, Fourth Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_18_15649=[""].join("\n");
var outline_f15_18_15649=null;
var title_f15_18_15650="Erythema multiforme palm";
var content_f15_18_15650=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F80715&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F80715&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Erythema multiforme",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Target lesions are present on the palm of this patient with erythema multiforme.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_18_15650=[""].join("\n");
var outline_f15_18_15650=null;
var title_f15_18_15651="Intraluminal retained surgical sponge";
var content_f15_18_15651=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F73101&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F73101&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 474px\">",
"   <div class=\"ttl\">",
"    Intraluminal retained surgical sponge",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 454px; height: 576px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Upper gastrointestinal contrast-enhanced study shows dilated small-bowel loop caused by presence of intraluminal foreign body (arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From: Manzella A, Filho PB, Albuquerque E, et al. Imaging of gossypibomas: pictorial review. AJR Am J Roentgenol 2009; 193(6 Suppl):S94. Reprinted with permission from the American Journal of Roentgenology. Copyright &copy; 2009 American Roentgen Ray Society.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_18_15651=[""].join("\n");
var outline_f15_18_15651=null;
var title_f15_18_15652="Anterior peritoneal reflection";
var content_f15_18_15652=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F51826&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F51826&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Identification of the anterior peritoneal reflection during vaginal hysterectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 425px; height: 385px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_18_15652=[""].join("\n");
var outline_f15_18_15652=null;
var title_f15_18_15653="Construction of an end colostomy segment through abdominal wall";
var content_f15_18_15653=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F55613&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F55613&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Construction of an end colostomy - segment through abdominal wall",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 450px; height: 692px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This figure shows the proximal end of the stapled colon being brought through the ostomy opening in the abdominal wall. The same approach is used when creating an end ileostomy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_18_15653=[""].join("\n");
var outline_f15_18_15653=null;
var title_f15_18_15654="Differential diagnosis of myasthenia gravis";
var content_f15_18_15654=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Differential diagnosis of myasthenia gravis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/18/15654/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/18/15654/contributors\">",
"     Shawn J Bird, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/18/15654/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/18/15654/contributors\">",
"     Jeremy M Shefner, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/18/15654/contributors\">",
"     Ira N Targoff, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/18/15654/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/18/15654/contributors\">",
"     John F Dashe, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?15/18/15654/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 27, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Myasthenia gravis (MG) is the most common disorder of neuromuscular transmission. The hallmark of the disorder is a fluctuating degree and variable combination of weakness in ocular, bulbar, limb, and respiratory muscles. Weakness is the result of an antibody-mediated, T-cell dependent immunological attack directed at proteins in the postsynaptic membrane of the neuromuscular junction (acetylcholine receptors or receptor-associated proteins). The diagnosis of MG can be established by clinical and serologic testing [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15654/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will discuss the differential diagnosis of MG, including conditions that mimic ocular myasthenia and conditions that mimic generalized myasthenia. The diagnosis of MG is discussed separately, as are other aspects of this disorder. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/12/32968?source=see_link\">",
"     \"Diagnosis of myasthenia gravis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/51/17206?source=see_link\">",
"     \"Clinical manifestations of myasthenia gravis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/35/31287?source=see_link\">",
"     \"Pathogenesis of myasthenia gravis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/57/7066?source=see_link\">",
"     \"Treatment of myasthenia gravis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33578208\">",
"    <span class=\"h1\">",
"     DIAGNOSIS OF MYASTHENIA GRAVIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of MG is reviewed here briefly and discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/12/32968?source=see_link\">",
"     \"Diagnosis of myasthenia gravis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The optimal approach to the diagnosis of myasthenia gravis varies with the clinical setting. The first step is to establish that the symptoms and signs are consistent with myasthenia gravis and not another disorder. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/51/17206?source=see_link\">",
"     \"Clinical manifestations of myasthenia gravis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The bedside ice pack test can be used to support the diagnosis of myasthenia gravis in patients with ptosis, but it is",
"    <strong>",
"     not",
"    </strong>",
"    helpful for those with extraocular muscle weakness. The",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/21/35156?source=see_link\">",
"     edrophonium",
"    </a>",
"    (Tensilon) test should be used only in those patients with obvious ptosis or ophthalmoparesis, in whom improvement after infusion of the drug can easily be observed. The sensitivity of the Tensilon test for the diagnosis of MG is in the range of 80 to 90 percent, but it is associated with many false-negative and false-positive results. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/12/32968?source=see_link&amp;anchor=H3#H3\">",
"     \"Diagnosis of myasthenia gravis\", section on 'Bedside tests'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The diagnosis of MG should be confirmed, if possible, by immunologic",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    electrophysiologic testing (",
"    <a class=\"graphic graphic_table graphicRef77349 \" href=\"UTD.htm?18/3/18491\">",
"     table 1",
"    </a>",
"    ). Because of its specificity, testing for autoantibodies against the acetylcholine receptor (AChR-Ab) should be performed on all patients. Demonstration of binding antibodies, possible in 80 to 90 percent of patients with generalized disease, provides the laboratory confirmation of myasthenia gravis. If the AChR-Abs are negative, an assay for antibodies to muscle specific tyrosine kinase (MuSK) should be performed. Antibodies to MuSK are present in 38 to 50 percent of those with AChR-Ab negative, generalized myasthenia. Seronegative myasthenia gravis, also called antibody-negative myasthenia gravis, refers to the 6 to 12 percent of patients with generalized myasthenia who have a negative standard assay for AChR-Ab and MuSK-Ab. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/12/32968?source=see_link&amp;anchor=H6#H6\">",
"     \"Diagnosis of myasthenia gravis\", section on 'Serologic testing'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Repetitive nerve stimulation (RNS) studies and single-fiber electromyography (SFEMG) have a diagnostic sensitivity in generalized myasthenia of about 75 percent and 95 percent, respectively. RNS studies should be performed first, followed by SFEMG, if the diagnosis is still uncertain. Electrophysiologic tests usually allow confirmation of the diagnosis in patients who have seronegative myasthenia gravis. They may be helpful in those with positive antibody studies as well, particularly if there are any unusual clinical features or a lack of response to immunotherapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/12/32968?source=see_link&amp;anchor=H12#H12\">",
"     \"Diagnosis of myasthenia gravis\", section on 'Electrophysiologic confirmation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Studies to exclude other diseases in the differential diagnosis of myasthenia gravis are also indicated in selected patients. For those with ocular or bulbar symptoms, an MRI of the brain is appropriate. CT scanning or ultrasound of the orbits is helpful in the differential diagnosis of ocular myasthenia and thyroid ophthalmopathy. Lumbar puncture may be necessary to exclude lymphomatous or carcinomatous meningitis with certain clinical presentations. Blood tests should include thyroid function tests. If there is clinical suspicion of an associated rheumatologic disorder, assays for antinuclear antibody and rheumatoid factor should also be performed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/12/32968?source=see_link&amp;anchor=H15#H15\">",
"     \"Diagnosis of myasthenia gravis\", section on 'Associated conditions'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL BY PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Differential diagnostic considerations early in the presentation of possible MG depend largely on the initial signs and symptoms. The correct diagnosis can usually be established by other clinical features on examination and the appropriate serologic and electrophysiologic studies.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ocular weakness, manifested by diplopia",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      ptosis, is the initial feature in about 50 percent of patients with MG. Other disorders to consider include those that mimic ocular MG.",
"     </li>",
"     <li>",
"      Bulbar symptoms, such as dysarthria or dysphagia, are the first abnormalities in about 15 percent of patients with MG. Motor neuron disease, obstructive lesions of the oropharynx, brainstem disorders, or multiple cranial nerve palsies may produce similar symptoms.",
"     </li>",
"     <li>",
"      Limb weakness as the sole early manifestation occurs in &lt;5 percent of patients with MG. Diagnostic considerations include motor neuron disease, chronic inflammatory demyelinating polyneuropathy and other motor neuropathies, Lambert-Eaton myasthenic syndrome, and myopathies.",
"     </li>",
"     <li>",
"      Isolated respiratory involvement is rare in MG, but may also occur in motor neuron disease and acid maltase deficiency myopathy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CONDITIONS THAT MIMIC OCULAR MYASTHENIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;The disorders that are likely to be confused with ocular MG involve weakness of both eyelid and oculomotor function, producing diplopia and ptosis. They include the following conditions:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Thyroid ophthalmopathy",
"     </li>",
"     <li>",
"      Chronic progressive external ophthalmoplegia",
"     </li>",
"     <li>",
"      Myotonic dystrophy and oculopharyngeal dystrophy",
"     </li>",
"     <li>",
"      Brainstem and motor cranial nerve pathology",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These conditions are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/53/7001?source=see_link&amp;anchor=H8#H8\">",
"     \"Ocular myasthenia gravis\", section on 'Differential diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CONDITIONS THAT MIMIC GENERALIZED MYASTHENIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are a number of neuromuscular disorders that can be confused with myasthenia clinically. This should always be kept in mind so that a careful history, physical examination, and laboratory testing can allow the correct diagnosis to be established. Electrodiagnostic studies are particularly crucial in the differential diagnosis of these other neuromuscular disorders.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Generalized fatigue",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although fatigable weakness may be a major aspect of MG, it is important to differentiate this from complaints of generalized fatigue or tiredness. This lack of energy, often described as overwhelming fatigue, is not part of MG and is never the sole manifestation. This symptom is generally due to an underlying medical disorder (eg, anemia), progressive deconditioning, or psychological etiology. In myasthenia, the symptoms usually include specific complaints of fatigable weakness. Examples include diplopia or ptosis that develop late in the day, difficulty with prolonged chewing, development of dysarthria or hypophonia with prolonged speech, or neck extensor weakness late in the day, with the inability to keep the head upright.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Motor neuron disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Amyotrophic lateral sclerosis (ALS) is a progressive disease that, like myasthenia, can involve the bulbar muscles, leading to facial weakness, dysarthria, or dysphagia. However, ptosis or ocular dysmotility producing diplopia as typically seen with MG are NOT features of ALS. Other manifestations that distinguish ALS from MG on clinical grounds are the presence of both upper motor neuron signs (hyperreflexia and Babinski signs) and lower motor neuron signs (atrophy and fasciculations) in ALS, together with its progressive nature. In addition, electrophysiologic studies are useful in differentiating these disorders. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/21/40280?source=see_link\">",
"     \"Clinical features of amyotrophic lateral sclerosis and other forms of motor neuron disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/34/16938?source=see_link\">",
"     \"Diagnosis of amyotrophic lateral sclerosis and other forms of motor neuron disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Of note, a false-positive Tensilon test can occur in ALS. In addition, a false-positive test for AChR-Ab is seen in approximately 3 to 5 percent of ALS patients, although usually in low titers [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15654/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Lambert-Eaton myasthenic syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Lambert-Eaton myasthenic syndrome (LEMS) shares with MG the involvement of the neuromuscular junction, and it has a similar pathophysiology (an autoimmune disease often associated with malignancy). However, the clinical presentation is different in LEMS [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15654/abstract/4\">",
"     4",
"    </a>",
"    ]. It is more often confused with myopathies. Proximal leg weakness, making it difficult for the patient to rise from a chair or to climb stairs, is typically the earliest and most prominent symptom. Less dramatic shoulder girdle weakness eventually occurs. Involvement of the bulbar muscles or diplopia is less common in LEMS than in MG, but ptosis is frequently seen. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/9/35992?source=see_link\">",
"     \"Clinical features and diagnosis of Lambert-Eaton myasthenic syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition to the differences in muscle distribution, there are several other important differences between LEMS and MG [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15654/abstract/4\">",
"     4",
"    </a>",
"    ]. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Symptoms in LEMS are more likely to be present in the morning and to improve with exercise.",
"     </li>",
"     <li>",
"      Autonomic dysfunction, such as erectile dysfunction in men or dry mouth, is a frequent symptom in LEMS.",
"     </li>",
"     <li>",
"      Repetitive nerve stimulation (RNS) at high rates (20 to 50 cycles per second) produces a marked increase in the compound muscle action potential (CMAP) amplitude (an incremental response) in patients with LEMS, as does brief exercise. In contrast, there is a lack of an incremental response in MG with high rate RNS or exercise.",
"     </li>",
"     <li>",
"      Approximately half of patients have cancer, usually small cell lung cancer.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The typical electrodiagnostic findings of LEMS and detection of serum antibodies to the presynaptic voltage-dependent calcium channels establishes the diagnosis of LEMS. LEMS is associated with specific autoantibodies. Over 95 percent of patients have antibodies against",
"    <span class=\"nowrap\">",
"     P/Q-type",
"    </span>",
"    calcium channels; in comparison, less than 5 percent of patients with myasthenia have such antibodies [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15654/abstract/5\">",
"     5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/27/37304?source=see_link&amp;anchor=H14#H14\">",
"     \"Paraneoplastic syndromes affecting peripheral nerve and muscle\", section on 'Lambert-Eaton myasthenic syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Occasional patients with LEMS have AChR-Ab [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15654/abstract/6\">",
"     6",
"    </a>",
"    ]. Distinction from MG in this setting is made by the presence of small cell lung cancer (in half), antibodies directed against the",
"    <span class=\"nowrap\">",
"     P/Q",
"    </span>",
"    type calcium channels, and the electrophysiological features of a presynaptic disorder of neuromuscular transmission [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15654/abstract/6\">",
"     6",
"    </a>",
"    ]. Rarely, a patient will have the clinical, immunological, and electrophysiological features of both disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15654/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Botulism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Botulism can be confused with myasthenia because it also prominently affects the bulbar and eye muscles. However, the botulinum toxin produces pupillary paralysis in approximately one-half of affected patients, whereas pupillary function is spared in MG. Botulism is further distinguished from MG by its rapid progression and its usual association with ingestion of food contaminated by Clostridium botulinum. The presynaptic localization of the abnormality in botulism can be confirmed by an incremental response during high-frequency RNS or after brief exercise, similar to that seen in LEMS. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/36/37448?source=see_link\">",
"     \"Botulism\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/45/41688?source=see_link&amp;anchor=H3#H3\">",
"     \"Overview of neuromuscular junction toxins\", section on 'Botulism'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Penicillamine-induced myasthenia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 1 percent of patients treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/6/4200?source=see_link\">",
"     penicillamine",
"    </a>",
"    , usually for rheumatoid arthritis or Wilson's disease, develop an autoimmune myasthenia gravis that shares many of the characteristics of primary MG [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15654/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. This occurs because penicillamine induces the production of AChR antibodies. This effect should not be confused with the exacerbation of MG that may occur due to drugs that pharmacologically interfere with neuromuscular transmission. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/57/7066?source=see_link\">",
"     \"Treatment of myasthenia gravis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Myasthenia induced by",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/6/4200?source=see_link\">",
"     penicillamine",
"    </a>",
"    usually resolves within 3 to 12 months once the drug is withdrawn [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15654/abstract/8\">",
"     8",
"    </a>",
"    ]. However, resolution of myasthenia may be quite slow, and treatment for myasthenia may be required if symptoms are severe. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/57/7066?source=see_link\">",
"     \"Treatment of myasthenia gravis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Statins and myasthenia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Statin treatment may be associated with a myasthenic syndrome or exacerbation of myasthenia symptoms. This issue is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/57/7066?source=see_link&amp;anchor=H25#H25\">",
"     \"Treatment of myasthenia gravis\", section on 'Drugs that may exacerbate myasthenia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Congenital myasthenic syndromes",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several rare forms of congenital myasthenic syndrome. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/10/166?source=see_link&amp;anchor=H7#H7\">",
"     \"Neuromuscular junction disorders in newborns and infants\", section on 'Congenital myasthenic syndromes'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    These genetic disorders should be considered when any of the following conditions are present [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15654/abstract/10-12\">",
"     10-12",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      A positive family history",
"     </li>",
"     <li>",
"      A lack of response to anticholinesterase drugs",
"     </li>",
"     <li>",
"      The absence of AChR or MuSK antibodies",
"     </li>",
"     <li>",
"      A history dating back to childhood.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients with congenital myasthenic syndromes usually have a long history of illness, often beginning in childhood, followed by slow, steady progression &ndash; a pattern that would be most unusual for autoimmune MG. Certain electrodiagnostic findings (eg, multiple CMAP responses to a single nerve stimulation) are a clue to a few of these disorders. The lack of a family history does not exclude these as a possibility, since there are recessive and sporadic forms.",
"   </p>",
"   <p>",
"    Although these conditions are not immune-mediated, they are confused with MG because they also involve dysfunction of the acetylcholine-mediated neuromuscular synaptic transmission. Presynaptic and postsynaptic dysfunction can all lead to varying patterns of weakness [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15654/abstract/10-12\">",
"     10-12",
"    </a>",
"    ]. Some presynaptic forms, usually with infantile onset, have abnormalities in acetylcholine packaging, resynthesis, or mobilization. In other forms of these disorders, the abnormalities are postsynaptic and are due to mutations in the acetylcholine receptor subunits. This results in gated channels that show either increased or reduced sensitivity to acetylcholine stimulation. Congenital end-plate acetylcholinesterase deficiency produces weakness due to depolarizing block from excessive ACh action postsynaptically.",
"   </p>",
"   <p>",
"    All of these disorders have electrophysiologic features of a disorder of neuromuscular transmission, similar to MG. This includes decremental responses on repetitive nerve stimulation at 2 to 3 Hertz, as well as increased jitter values on single-fiber electromyography. Some forms (eg, slow channel syndrome and end-plate acetylcholinesterase deficiency) have a characteristic electrophysiologic finding of multiple motor (CMAP) responses after a single nerve stimulation.",
"   </p>",
"   <p>",
"    In suspected cases, molecular genetic testing may sometimes confirm the diagnosis. In many, physiologic analysis of an intercostal muscle biopsy is necessary to confirm the diagnosis. These studies are not widely available.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many of the disorders that are likely to be confused with myasthenia gravis (MG) involve weakness of the extraocular muscles. The diagnosis of ocular myasthenia is often difficult to establish with certainty, since the confirmatory tests are often negative.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The diagnosis of MG should be confirmed, if possible, by immunologic",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      electrophysiologic testing. (See",
"      <a class=\"local\" href=\"#H33578208\">",
"       'Diagnosis of myasthenia gravis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The differential diagnosis of ocular MG includes Grave's disease, chronic progressive external ophthalmoplegia (CPEO), as well as multiple cranial neuropathies from structural or inflammatory disease of the brainstem and basilar meninges (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/53/7001?source=see_link\">",
"       \"Ocular myasthenia gravis\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Generalized fatigue and a number of neuromuscular disorders can also be confused with myasthenia. Electrodiagnostic studies are particularly crucial in the differential diagnosis of these other neuromuscular disorders.",
"     </li>",
"     <li>",
"      Fatigable weakness, an important aspect of MG, must be distinguished from complaints of generalized fatigue or tiredness. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Generalized fatigue'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Amyotrophic lateral sclerosis (ALS) is a progressive disease that, like myasthenia, can involve the bulbar muscles and can produce a false-positive Tensilon test and even rarely a false-positive test for AChR-Ab. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Motor neuron disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The Lambert-Eaton myasthenic syndrome (LEMS) shares the same pathologic site with MG and has a similar pathophysiology. However, the clinical presentation in LEMS is markedly different than in MG. Proximal leg weakness is typically the earliest and most prominent symptom. Involvement of the bulbar muscles or diplopia is rare, but ptosis is frequently seen. Symptoms in LEMS are more likely to be present in the morning and to improve with exercise. Autonomic dysfunction is frequent in LEMS. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Lambert-Eaton myasthenic syndrome'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Botulism can be confused with myasthenia because it also prominently affects the bulbar and eye muscles. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Botulism'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      An autoimmune form of MG occurs in approximately 1 percent of patients treated with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/6/4200?source=see_link\">",
"       penicillamine",
"      </a>",
"      . (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Penicillamine-induced myasthenia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There are several rare forms of congenital myasthenic syndromes. They should be considered when there is a positive family history, a lack of response to anticholinesterase drugs, the absence of AChR or MuSK antibodies, or a history dating back to childhood. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Congenital myasthenic syndromes'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15654/abstract/1\">",
"      Drachman DB. Myasthenia gravis. N Engl J Med 1994; 330:1797.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15654/abstract/2\">",
"      Keesey JC. Clinical evaluation and management of myasthenia gravis. Muscle Nerve 2004; 29:484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15654/abstract/3\">",
"      Mittag TW, Caroscio J. False-positive immunoassay for acetylcholine-receptor antibody in amyotrophic lateral sclerosis. N Engl J Med 1980; 302:868.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15654/abstract/4\">",
"      O'Neill JH, Murray NM, Newsom-Davis J. The Lambert-Eaton myasthenic syndrome. A review of 50 cases. Brain 1988; 111 ( Pt 3):577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15654/abstract/5\">",
"      Lennon VA, Kryzer TJ, Griesmann GE, et al. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N Engl J Med 1995; 332:1467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15654/abstract/6\">",
"      Vernino S, Adamski J, Kryzer TJ, et al. Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer-related syndromes. Neurology 1998; 50:1806.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15654/abstract/7\">",
"      Oh SJ, Sher E. MG and LEMS overlap syndrome: case report with electrophysiological and immunological evidence. Clin Neurophysiol 2005; 116:1167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15654/abstract/8\">",
"      Albers JW, Hodach RJ, Kimmel DW, Treacy WL. Penicillamine-associated myasthenia gravis. Neurology 1980; 30:1246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15654/abstract/9\">",
"      Adelman HM, Winters PR, Mahan CS, Wallach PM. D-penicillamine-induced myasthenia gravis: diagnosis obscured by coexisting chronic obstructive pulmonary disease. Am J Med Sci 1995; 309:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15654/abstract/10\">",
"      Engel AG, Ohno K, Sine SM. Congenital myasthenic syndromes: recent advances. Arch Neurol 1999; 56:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15654/abstract/11\">",
"      Harper CM. Congenital myasthenic syndromes. Semin Neurol 2004; 24:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15654/abstract/12\">",
"      Nogajski JH, Kiernan MC, Ouvrier RA, Andrews PI. Congenital myasthenic syndromes. J Clin Neurosci 2009; 16:1.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5168 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-122.72.76.133-E4AAF914B2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_18_15654=[""].join("\n");
var outline_f15_18_15654=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H33578208\">",
"      DIAGNOSIS OF MYASTHENIA GRAVIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DIFFERENTIAL BY PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CONDITIONS THAT MIMIC OCULAR MYASTHENIA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CONDITIONS THAT MIMIC GENERALIZED MYASTHENIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Generalized fatigue",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Motor neuron disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Lambert-Eaton myasthenic syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Botulism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Penicillamine-induced myasthenia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Statins and myasthenia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Congenital myasthenic syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/5168\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/5168|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?18/3/18491\" title=\"table 1\">",
"      Sensitivity of tests for MG",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/36/37448?source=related_link\">",
"      Botulism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/9/35992?source=related_link\">",
"      Clinical features and diagnosis of Lambert-Eaton myasthenic syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/21/40280?source=related_link\">",
"      Clinical features of amyotrophic lateral sclerosis and other forms of motor neuron disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/51/17206?source=related_link\">",
"      Clinical manifestations of myasthenia gravis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/34/16938?source=related_link\">",
"      Diagnosis of amyotrophic lateral sclerosis and other forms of motor neuron disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/12/32968?source=related_link\">",
"      Diagnosis of myasthenia gravis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/10/166?source=related_link\">",
"      Neuromuscular junction disorders in newborns and infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/53/7001?source=related_link\">",
"      Ocular myasthenia gravis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/45/41688?source=related_link\">",
"      Overview of neuromuscular junction toxins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/27/37304?source=related_link\">",
"      Paraneoplastic syndromes affecting peripheral nerve and muscle",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/35/31287?source=related_link\">",
"      Pathogenesis of myasthenia gravis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/57/7066?source=related_link\">",
"      Treatment of myasthenia gravis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f15_18_15655="Osteoblastic metastases to the lumbar spine";
var content_f15_18_15655=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RADIOL%2F83139&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RADIOL%2F83139&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 551px\">",
"   <div class=\"ttl\">",
"    Prostate cancer: Osteoblastic metastases to the lumbar spine",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 531px; height: 538px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The patient is a 50-year-old man with metastatic prostate carcinoma. Image (A) is a CT reconstruction of the lumbar spine and shows extensive blastic metastases involving almost all the visualized bones with lytic and compressive changes in T11 (red arrow). The T2 weighted MRI (B) shows heterogeneous changes within the bone marrow consistent with metastatic disease. The findings are consistent with extensive metastases from primary prostate carcinoma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_18_15655=[""].join("\n");
var outline_f15_18_15655=null;
var title_f15_18_15656="Dobutamine stress echocardiography in the evaluation of hibernating myocardium";
var content_f15_18_15656=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Dobutamine stress echocardiography in the evaluation of hibernating myocardium",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/18/15656/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/18/15656/contributors\">",
"     Wilson S Colucci, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/18/15656/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/18/15656/contributors\">",
"     Warren J Manning, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/18/15656/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/18/15656/contributors\">",
"     Brian C Downey, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?15/18/15656/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 19, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Impaired left ventricular (LV) systolic function in patients with coronary heart disease is often a partially reversible process (",
"    <a class=\"graphic graphic_table graphicRef52865 \" href=\"UTD.htm?27/52/28491\">",
"     table 1",
"    </a>",
"    ). As an example, left ventricular function may improve markedly, and even normalize, in subsets of patients following successful revascularization (",
"    <a class=\"graphic graphic_figure graphicRef55621 \" href=\"UTD.htm?10/24/10638\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15656/abstract/1-3\">",
"     1-3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Since many studies have established a relation between LV systolic function and cardiovascular prognosis, it is reasonable to speculate that improved LV systolic function following revascularization would be associated with a favorable effect on outcome. The superiority of revascularization compared to medical management in selected patients with coronary disease and LV dysfunction is compatible with this hypothesis [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15656/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. The myocardium that recovers function after revascularization has been called \"hibernating.\" To the extent that improvement in regional or global LV systolic function is a significant goal in such patients, the ability to accurately assess regional myocardial viability in a dysfunctional territory prior to revascularization becomes an important component of the decision making process (",
"    <a class=\"graphic graphic_table graphicRef63612 \" href=\"UTD.htm?24/56/25483\">",
"     table 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_algorithm graphicRef70975 \" href=\"UTD.htm?43/11/44222\">",
"     algorithm 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_algorithm graphicRef67744 \" href=\"UTD.htm?39/41/40607\">",
"     algorithm 2",
"    </a>",
"    ). (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/3/24633?source=see_link&amp;anchor=H12#H12\">",
"     \"Diagnosis and management of ischemic cardiomyopathy\", section on 'Revascularization'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/35/8759?source=see_link\">",
"     \"Clinical syndromes of stunned or hibernating myocardium\"",
"    </a>",
"    )",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"     Dobutamine",
"    </a>",
"    stress echocardiography has emerged as an important noninvasive clinical tool for the detection of hibernating myocardium [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15656/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. The role of dobutamine stress echocardiography in the evaluation of myocardial viability in the setting of hibernation will be reviewed here. The use of other modalities in conjunction with dobutamine stress, such as Doppler studies, the relative efficacy of other imaging modalities (eg, radionuclide imaging, magnetic resonance imaging) for the detection of hibernating myocardium, and protocols for dobutamine stress echocardiography are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/41/10905?source=see_link\">",
"     \"Evaluation of hibernating myocardium\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/31/35319?source=see_link&amp;anchor=H7#H7\">",
"     \"Protocols for stress echocardiography\", section on 'Dobutamine stress echocardiography'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/5/41048?source=see_link\">",
"     \"Stress echocardiography: Indications, imaging techniques and safety\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DOBUTAMINE STRESS ECHOCARDIOGRAPHY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pharmacologic stress echocardiography examines the \"inotropic reserve\" of dysfunctional but viable myocardium at rest by the administration of an inotropic agent, with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    being the most frequently used agent. Viable myocardium shows improved global or regional contractile function (inotropic reserve), as assessed by simultaneous transthoracic echocardiography, in response to inotrope administration [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15656/abstract/8\">",
"     8",
"    </a>",
"    ]. The prevalence of contractile reserve in patients with CHD and LV dysfunction is independent of the angiographic extent and severity of coronary artery disease, and the improvement in contractility in hypoperfused viable myocardium does not require an increase in regional myocardial perfusion [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15656/abstract/9,10\">",
"     9,10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A contractile response to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    appears to require that at least 50 percent of the myocytes in a given segment are viable; the contractile response also correlates inversely with the extent of interstitial fibrosis on myocardial biopsy [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15656/abstract/11\">",
"     11",
"    </a>",
"    ]. In comparison, radionuclide myocardial perfusion imaging identifies segments with fewer viable myocytes. In one series, for example, dobutamine stress echocardiography and thallium imaging showed equivalent sensitivity among segments with more than 75 percent viable myocytes (78 versus 87 percent) but dobutamine stress echocardiography was much less sensitive among segments with 25 to 50 percent viable myocytes (15 versus 82 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15656/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The predictive value of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    stress echocardiography appears to be greatest when there is a biphasic response: improvement at low dose and worsening at high-dose dobutamine [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15656/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. The initial improvement in wall motion reflects recruitment of contractile reserve during low-dose dobutamine, and hence reflects viability [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15656/abstract/15\">",
"     15",
"    </a>",
"    ]. In comparison, higher doses lead to subendocardial ischemia and worsening of the wall motion abnormality, identifying stress-induced ischemia. Thus, testing at various doses appears to be important for the optimal assessment of myocardial hibernation by this technique.",
"   </p>",
"   <p>",
"    The concurrent use of beta blockers at the time of the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    stress echocardiogram can affect the response to dobutamine and reduce the number of viable segments detected [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15656/abstract/16\">",
"     16",
"    </a>",
"    ]. If a study during beta blocker therapy shows only limited viability, it may be useful to repeat the test after the dose has been reduced. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/31/35319?source=see_link&amp;anchor=H7#H7\">",
"     \"Protocols for stress echocardiography\", section on 'Dobutamine stress echocardiography'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Improvement in LV function after CABG",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"     Dobutamine",
"    </a>",
"    stress echocardiography can be used to identify hibernating myocardium prior to coronary artery bypass graft (CABG) surgery. Several studies have shown that it can be used to predict the likelihood of recovery after CABG [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15656/abstract/13,17,18\">",
"     13,17,18",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among 18 patients with coronary disease and LV systolic dysfunction who underwent two-dimensional echocardiography at rest and during",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"       dobutamine",
"      </a>",
"      infusion, 61 percent of dysfunctional segments with inotropic reserve showed improved regional systolic function after CABG [",
"      <a class=\"abstract\" href=\"UTD.htm?15/18/15656/abstract/17\">",
"       17",
"      </a>",
"      ]. The positive and negative predictive accuracy of dobutamine infusion for predicting functional improvement of dysfunctional segments after CABG was 91 and 82 percent, respectively.",
"     </li>",
"     <li>",
"      Among 61 patients who underwent serial",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"       dobutamine",
"      </a>",
"      stress echocardiography and radionuclide ventriculography prior to CABG, a biphasic response (improvement at low dose and worsening at high dose dobutamine) was highly predictive of recovery, especially in segments with the most severe wall motion abnormalities at baseline [",
"      <a class=\"abstract\" href=\"UTD.htm?15/18/15656/abstract/13\">",
"       13",
"      </a>",
"      ]. Other patterns of dobutamine responsiveness were predictors of non-recovery (",
"      <a class=\"graphic graphic_figure graphicRef61817 \" href=\"UTD.htm?26/42/27309\">",
"       figure 2",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      In a series of 133 patients, those with the largest amount of dysfunctional but viable myocardium, defined as &ge;6 segments improving with low-dose",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"       dobutamine",
"      </a>",
"      , had the greatest functional improvement in left ventricular ejection fraction after surgical revascularization and a lower rate of cardiac events during a 20 month follow-up [",
"      <a class=\"abstract\" href=\"UTD.htm?15/18/15656/abstract/18\">",
"       18",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    While a biphasic response to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    is predictive of mechanical recovery after CABG, the amount of dysfunctional but viable myocardium may be a better predictor of long term outcome. This was suggested by a study of 95 patients in whom multiple indices of viability were measured by dobutamine stress echocardiography prior to CABG [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15656/abstract/19\">",
"     19",
"    </a>",
"    ]. After a five year follow up, the amount of dysfunctional but viable myocardium, as assessed by wall motion score during low dose dobutamine, was the most important independent predictor of survival (hazard ratio [HR] 6.7, 95% CI 2.8 to 15.8). A biphasic response to dobutamine, while significant on multivariable analysis, was less important.",
"   </p>",
"   <p>",
"    The predictive value of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    stress echocardiography is similar to that of positron emission tomography (PET) scanning (",
"    <a class=\"graphic graphic_figure graphicRef79730 \" href=\"UTD.htm?16/39/17022\">",
"     figure 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15656/abstract/20\">",
"     20",
"    </a>",
"    ]. The accuracy is less, however, when there is a totally occluded coronary artery [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15656/abstract/21\">",
"     21",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/41/10905?source=see_link&amp;anchor=H3#H3\">",
"     \"Evaluation of hibernating myocardium\", section on 'Efficacy of imaging tests'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Improvement in LV systolic function after percutaneous revascularization",
"    </span>",
"    &nbsp;&mdash;&nbsp;The accuracy of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    stress echocardiography for predicting recovery of LV function after percutaneous revascularization in patients with stable coronary disease and LV dysfunction has also been evaluated.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a study of 20 patients undergoing",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"       dobutamine",
"      </a>",
"      stress echocardiography, the accurate prediction of recoverability of contractile function depended upon the type of wall motion response observed during dobutamine [",
"      <a class=\"abstract\" href=\"UTD.htm?15/18/15656/abstract/14\">",
"       14",
"      </a>",
"      ].The greatest improvement in LV systolic function was seen in patients with a biphasic response to dobutamine, with less improvement in patients with either no change or sustained improvement after dobutamine.",
"     </li>",
"     <li>",
"      The administration of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?11/24/11656?source=see_link\">",
"       nitroglycerin",
"      </a>",
"      may improve the accuracy of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"       dobutamine",
"      </a>",
"      stress echocardiography in detecting viable myocardium. In an animal model, nitroglycerin enhanced the improvement with low dose dobutamine but did not prevent high dose dobutamine from inducing ischemia in hibernating myocardium [",
"      <a class=\"abstract\" href=\"UTD.htm?15/18/15656/abstract/22\">",
"       22",
"      </a>",
"      ]. The clinical efficacy of nitroglycerin-dobutamine echocardiography was evaluated in a study of 32 patients in whom 309 of 512 myocardial segments were akinetic or dyskinetic [",
"      <a class=\"abstract\" href=\"UTD.htm?15/18/15656/abstract/23\">",
"       23",
"      </a>",
"      ]. In terms of improved contractility after revascularization, nitroglycerin-dobutamine echocardiography had a lower sensitivity than rest-redistribution thallium and myocardial contrast echocardiography (63 versus 95 and 87 percent, respectively), but was the most specific (83 versus 37 and 48 percent). Nitroglycerin alone increased regional thickening in 20 percent of viable akinetic segments, suggesting that it may be a useful addition to dobutamine stimulation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Improvement in survival after revascularization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with left ventricular systolic dysfunction who demonstrate myocardial viability with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    stress echocardiography have a better outcome with revascularization than with medical therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15656/abstract/15,24,25\">",
"     15,24,25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a study of 318 patients with coronary heart disease and a left ventricular ejection fraction &le;35 percent, those with myocardial viability (as determined by",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"       dobutamine",
"      </a>",
"      stress echocardiography) had a lower mortality at 18 months when treated with coronary artery bypass graft (CABG) surgery compared to those with viability who were treated medically or those without viability who underwent CABG (6 versus 20 and 17 percent, respectively) [",
"      <a class=\"abstract\" href=\"UTD.htm?15/18/15656/abstract/24\">",
"       24",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The results of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"       dobutamine",
"      </a>",
"      stress echocardiography can also predict long-term outcome [",
"      <a class=\"abstract\" href=\"UTD.htm?15/18/15656/abstract/15,25\">",
"       15,25",
"      </a>",
"      ]. In a study of 87 patients with heart failure due to an ischemic cardiomyopathy who were followed for 40 months, cardiac mortality in patients with at least 5 (out of 12) segments showing myocardial viability who underwent CABG was 3 percent, with associated improvement in functional class and left ventricular ejection fraction [",
"      <a class=\"abstract\" href=\"UTD.htm?15/18/15656/abstract/25\">",
"       25",
"      </a>",
"      ]. In contrast, cardiac mortality was 31, 50, and 44 percent in those with myocardial viability in at least 5 segments who were treated medically and in those with less than 5 segments showing myocardial viability who underwent revascularization or medical therapy, respectively.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Similar mortality benefits have been reported with all of the major imaging techniques for the detection of myocardial viability. In a meta-analysis of 24 viability studies (with viability determined by",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    echocardiography, thallium perfusion imaging, or positron emission tomography (PET) scanning) involving 3088 patients with coronary artery disease and left ventricular dysfunction, myocardial viability was present in 42 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15656/abstract/26\">",
"     26",
"    </a>",
"    ]. The patients with myocardial viability had an 80 percent reduction in annual mortality with revascularization (3.2 versus 16 percent with medical therapy). In contrast, there was no difference in annual mortality with revascularization in patients without myocardial viability (annual mortality 7.7 versus 6.2 percent with medical therapy).",
"   </p>",
"   <p>",
"    A similar difference in mortality was noted in another review in which annual mortality was reduced after revascularization only in patients with myocardial viability (7 versus 20 percent with medical therapy) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15656/abstract/27\">",
"     27",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/3/24633?source=see_link&amp;anchor=H12#H12\">",
"     \"Diagnosis and management of ischemic cardiomyopathy\", section on 'Revascularization'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Use after MI",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"     Dobutamine",
"    </a>",
"    stress echocardiography is also useful for establishing the presence of hibernating myocardium due to a residual stenosis following a myocardial infarction (MI). In one series of 232 patients undergoing a dobutamine-atropine stress echocardiography within one week after MI, the presence of either an ischemic or a biphasic response in two or more contiguous infarction zones was both sensitive (82 percent) and specific (80 percent) for a residual stenosis and had a predictive accuracy of 82 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15656/abstract/28\">",
"     28",
"    </a>",
"    ]. Sensitivity was greatest when a biphasic response was observed. In another study sustained improvement with high dose dobutamine was the most specific predictor (100 percent) for the absence of significant residual stenosis [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15656/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"     Dobutamine",
"    </a>",
"    stress echocardiography is also of use for predicting recovery and the extent of irreversibly damaged myocardium after direct angioplasty in patients with an acute MI [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15656/abstract/30\">",
"     30",
"    </a>",
"    ]. Its predictive value for improvement is higher for hypokinetic than akinetic segments. Recovery of rest regional LV contraction usually occurs quickly after revascularization, although one-quarter of patients require up to six weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15656/abstract/31\">",
"     31",
"    </a>",
"    ]. Patients who recover rest function after angioplasty show the most marked improvement with dobutamine; however, some improvement may be seen in those without recovery of rest function, particularly when there was evidence of ischemia before revascularization.",
"   </p>",
"   <p>",
"    Although",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    stress echocardiography is useful for predicting recovery, dysfunctional but viable segments may show less improvement in basal contractility after revascularization than predicted. As an example, one study performed dobutamine stress echocardiography more than three months after CABG [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15656/abstract/32\">",
"     32",
"    </a>",
"    ]. Most infarct zones which showed contractile reserve before surgery but which failed to recover after surgery had the same or greater contractile reserve with dobutamine; some contractile reserve was present even in those infarct zones that showed no reserve preoperatively [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15656/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Use in LV dysfunction after MI",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"     Dobutamine",
"    </a>",
"    stress echocardiography after a myocardial infarction (MI) can identify residual, ischemic viable myocardium which can act as a substrate for further events.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one study of 138 patients with left ventricular (LV) dysfunction following MI, the presence of myocardial viability was the only independent predictor of recurrent ischemic events (20 versus 7 percent without viable myocardium) [",
"      <a class=\"abstract\" href=\"UTD.htm?15/18/15656/abstract/33\">",
"       33",
"      </a>",
"      ]. However, viability in the absence of underlying ischemia may be protective in patients with global LV dysfunction after MI in whom the recovery of LV function can offset the risk of ischemia.",
"     </li>",
"     <li>",
"      In another study evaluating 314 patients with moderate to severe resting LV dysfunction after an MI, the presence and extent of viability was associated with a lower mortality at 9 months (1.9 versus 5.5 percent for no viability) [",
"      <a class=\"abstract\" href=\"UTD.htm?15/18/15656/abstract/34\">",
"       34",
"      </a>",
"      ]. In patients with a greater number of segments showing improvement, there was a larger impact of viability on survival. In contrast, the presence of inducible ischemia was the best predictor of cardiac death.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Comparison with perfusion imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Direct comparisons between nuclear imaging techniques and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    stress echocardiography are limited. However, when used for the assessment of myocardial viability and hibernating myocardium, dobutamine stress echocardiography has both a high negative predictive value as well as a high positive predictive value (",
"    <a class=\"graphic graphic_figure graphicRef50864 \" href=\"UTD.htm?43/30/44526\">",
"     figure 4",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/41/10905?source=see_link&amp;anchor=H13#H13\">",
"     \"Evaluation of hibernating myocardium\", section on 'Pooled analysis of rMPI and DE studies'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Comparison with CMR",
"    </span>",
"    &nbsp;&mdash;&nbsp;Late gadolinium enhancement cardiovascular magnetic resonance imaging (CMR) can accurately discriminate nonviable from viable myocardial segments. However, the accuracy of low-dose",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    CMR and low-dose dobutamine echocardiography is not known as they have not been directly compared. However, in a comparative study using high-dose dobutamine stress echocardiography and dobutamine CMR, CMR had a higher sensitivity and specificity for detection of viable segments. This was primarily related to nonvisualization of segments on surface echocardiography. Comparison of late gadolinium enhancement CMR versus low dose dobutamine stress CMR suggests that low dose dobutamine CMR is superior, primarily related to improved accuracy for patients with intermediate late gadolinium enhancement pattern. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/3/34874?source=see_link&amp;anchor=H36992887#H36992887\">",
"     \"Clinical utility of cardiovascular magnetic resonance imaging\", section on 'Myocardial viability'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Role in idiopathic dilated cardiomyopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"     Dobutamine",
"    </a>",
"    stress echocardiography is useful for establishing the prognosis of patients with an idiopathic dilated cardiomyopathy, as an improvement in left ventricular contractility (ejection fraction or wall motion score) predicts a lower incidence of cardiac death or need for transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15656/abstract/35,36\">",
"     35,36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In one of the largest prospective studies,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    stress echocardiography was performed using high-dose dobutamine (up to 40",
"    <span class=\"nowrap\">",
"     &micro;g/kg",
"    </span>",
"    per min) in 184 patients with a left ventricular ejection fraction less than 30 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15656/abstract/35\">",
"     35",
"    </a>",
"    ]. After a 15 month follow-up, patients with a large inotropic response to dobutamine (defined as a change in wall motion score index &ge;0.44) had a significantly better survival (94 versus 69 percent for a small or no response to dobutamine). A large change in wall motion score index was an independent predictor of outcome on multivariate analysis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/48/33546?source=see_link\">",
"     \"Predictors of survival in heart failure due to systolic dysfunction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     ENOXIMONE STRESS ECHOCARDIOGRAPHY",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"     Dobutamine",
"    </a>",
"    stress echocardiography is widely used to assess myocardial viability, but the inotropic response to adrenergic stimulation may be attenuated in patients receiving a beta blocker. In addition, dobutamine may sometimes induce ischemia in patients with a critical coronary stenosis, which might mask hibernation by preventing the improvement in wall motion.",
"   </p>",
"   <p>",
"    An alternative approach is the use of a phosphodiesterase inhibitor such as enoximone or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/18/3366?source=see_link\">",
"     milrinone",
"    </a>",
"    , drugs which have been used for inotropic support in the treatment of heart failure. These drugs are relatively unaffected by concurrent use of a beta blocker. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/63/38906?source=see_link\">",
"     \"Overview of the therapy of heart failure due to systolic dysfunction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The possible role of enoximone stress echocardiography was evaluated in one study of 45 patients with chronic coronary artery disease and left ventricular dysfunction who underwent echocardiography with both",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    and enoximone [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15656/abstract/37\">",
"     37",
"    </a>",
"    ]. Both increased heart rate, but enoximone did not cause a change in systolic blood pressure. Concordant results were seen in 85 percent of affected segments, but enoximone had a higher sensitivity (88 versus 79 percent for dobutamine) and negative predictive value (90 versus 84 percent) in predicting functional recovery after revascularization. Specificity and positive predictive value were similar between enoximone and dobutamine.",
"   </p>",
"   <p>",
"    While enoximone is not approved for use in the United States, the pharmacology of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/18/3366?source=see_link\">",
"     milrinone",
"    </a>",
"    is very similar, and this agent could be considered for use as a pharmacologic stress agent in selected patients on beta blockers. Given the limited data, however, we feel that further investigations are required to validate this approach.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, \"The Basics\" and \"Beyond the Basics.\" The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on \"patient info\" and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?24/13/24787?source=see_link\">",
"       \"Patient information: Echocardiogram (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12791804\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"       Dobutamine",
"      </a>",
"      stress echocardiography is an important noninvasive clinical tool for the detection of viable \"hibernating\" myocardium, or myocardium that recovers systolic function after revascularization. Viable myocardium shows improved global (ejection fraction) or regional contractile function (inotropic reserve) in response to inotrope administration. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Dobutamine stress echocardiography'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      When performed on patients with ischemic heart disease and left ventricular dysfunction,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"       dobutamine",
"      </a>",
"      stress echocardiography predicts the likelihood of left ventricular functional recovery following both surgical and percutaneous revascularization. In addition, in patients with left ventricular dysfunction post-myocardial infarction who have not undergone revascularization, dobutamine stress echocardiography is useful for establishing the presence of hibernating myocardium due to a residual stenosis. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Improvement in LV function after CABG'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4\">",
"       'Improvement in LV systolic function after percutaneous revascularization'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H6\">",
"       'Use after MI'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with left ventricular dysfunction who demonstrate myocardial viability with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"       dobutamine",
"      </a>",
"      stress echocardiography have a better survival with revascularization than with medical therapy. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Improvement in survival after revascularization'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Direct comparisons between radionuclide imaging and cardiovascular magnetic resonance imaging techniques and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"       dobutamine",
"      </a>",
"      stress echocardiography in the same patients are limited. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Comparison with perfusion imaging'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/41/10905?source=see_link&amp;anchor=H13#H13\">",
"       \"Evaluation of hibernating myocardium\", section on 'Pooled analysis of rMPI and DE studies'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15656/abstract/1\">",
"      Rees G, Bristow JD, Kremkau EL, et al. Influence of aortocoronary bypass surgery on left ventricular performance. N Engl J Med 1971; 284:1116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15656/abstract/2\">",
"      Chatterjee K, Swan HJ, Parmley WW, et al. Influence of direct myocardial revascularization on left ventricular asynergy and function in patients with coronary heart disease. With and without previous myocardial infarction. Circulation 1973; 47:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15656/abstract/3\">",
"      Brundage BH, Massie BM, Botvinick EH. Improved regional ventricular function after successful surgical revascularization. J Am Coll Cardiol 1984; 3:902.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15656/abstract/4\">",
"      Alderman EL, Fisher LD, Litwin P, et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation 1983; 68:785.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15656/abstract/5\">",
"      Pigott JD, Kouchoukos NT, Oberman A, Cutter GR. Late results of surgical and medical therapy for patients with coronary artery disease and depressed left ventricular function. J Am Coll Cardiol 1985; 5:1036.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15656/abstract/6\">",
"      Beckmann S, Schartl M, Bocksch W, Fleck E. Diagnosis of coronary artery disease and viable myocardium by stress echocardiography. Diagnostic accuracy of different stress modalities. Eur Heart J 1995; 16 Suppl J:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15656/abstract/7\">",
"      Cheirif J, Murgo JP. Assessment of myocardial viability by dobutamine echocardiography. Coron Artery Dis 1995; 6:600.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15656/abstract/8\">",
"      Rocchi G, Poldermans D, Bax JJ, et al. Usefulness of the ejection fraction response to dobutamine infusion in predicting functional recovery after coronary artery bypass grafting in patients with left ventricular dysfunction. Am J Cardiol 2000; 85:1440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15656/abstract/9\">",
"      Main ML, Grayburn PA, Landau C, Afridi I. Relation of contractile reserve during low-dose dobutamine echocardiography and angiographic extent and severity of coronary artery disease in the presence of left ventricular dysfunction. Am J Cardiol 1997; 79:1309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15656/abstract/10\">",
"      Barill&agrave; F, De Vincentis G, Mangieri E, et al. Recovery of contractility of viable myocardium during inotropic stimulation is not dependent on an increase of myocardial blood flow in the absence of collateral filling. J Am Coll Cardiol 1999; 33:697.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15656/abstract/11\">",
"      Nagueh SF, Mikati I, Weilbaecher D, et al. Relation of the contractile reserve of hibernating myocardium to myocardial structure in humans. Circulation 1999; 100:490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15656/abstract/12\">",
"      Baumgartner H, Porenta G, Lau YK, et al. Assessment of myocardial viability by dobutamine echocardiography, positron emission tomography and thallium-201 SPECT: correlation with histopathology in explanted hearts. J Am Coll Cardiol 1998; 32:1701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15656/abstract/13\">",
"      Cornel JH, Bax JJ, Elhendy A, et al. Biphasic response to dobutamine predicts improvement of global left ventricular function after surgical revascularization in patients with stable coronary artery disease: implications of time course of recovery on diagnostic accuracy. J Am Coll Cardiol 1998; 31:1002.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15656/abstract/14\">",
"      Afridi I, Kleiman NS, Raizner AE, Zoghbi WA. Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation 1995; 91:663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15656/abstract/15\">",
"      Sawada SG, Lewis SJ, Foltz J, et al. Usefulness of rest and low-dose dobutamine wall motion scores in predicting survival and benefit from revascularization in patients with ischemic cardiomyopathy. Am J Cardiol 2002; 89:811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15656/abstract/16\">",
"      Poldermans, D, Sozzi, FB, Bax, JJ, et al. Influence of continuation of beta blockers during dobutamine stress echocardiography for the assessment of myocardial viability in patients with severe ischemic left ventricular dysfunction. Am J Cardiol 2001; 88:A7, 68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15656/abstract/17\">",
"      Perrone-Filardi P, Pace L, Prastaro M, et al. Dobutamine echocardiography predicts improvement of hypoperfused dysfunctional myocardium after revascularization in patients with coronary artery disease. Circulation 1995; 91:2556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15656/abstract/18\">",
"      Meluz&iacute;n J, Cern&yacute; J, Fr&eacute;lich M, et al. Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction. Investigators of this Multicenter Study. J Am Coll Cardiol 1998; 32:912.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15656/abstract/19\">",
"      Sawada S, Bapat A, Vaz D, et al. Incremental value of myocardial viability for prediction of long-term prognosis in surgically revascularized patients with left ventricular dysfunction. J Am Coll Cardiol 2003; 42:2099.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15656/abstract/20\">",
"      Baer FM, Voth E, Deutsch HJ, et al. Predictive value of low dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization. J Am Coll Cardiol 1996; 28:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15656/abstract/21\">",
"      Piscione F, Perrone-Filardi P, De Luca G, et al. Low dose dobutamine echocardiography for predicting functional recovery after coronary revascularisation. Heart 2001; 86:679.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15656/abstract/22\">",
"      Ma L, Chen L, Gillam L, et al. Nitroglycerin enhances the ability of dobutamine stress echocardiography to detect hibernating myocardium. Circulation 1997; 96:3992.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15656/abstract/23\">",
"      Ling LH, Christian TF, Mulvagh SL, et al. Determining myocardial viability in chronic ischemic left ventricular dysfunction: a prospective comparison of rest-redistribution thallium 201 single-photon emission computed tomography, nitroglycerin-dobutamine echocardiography, and intracoronary myocardial contrast echocardiography. Am Heart J 2006; 151:882.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15656/abstract/24\">",
"      Afridi I, Grayburn PA, Panza JA, et al. Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction. J Am Coll Cardiol 1998; 32:921.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15656/abstract/25\">",
"      Senior R, Kaul S, Lahiri A. Myocardial viability on echocardiography predicts long-term survival after revascularization in patients with ischemic congestive heart failure. J Am Coll Cardiol 1999; 33:1848.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15656/abstract/26\">",
"      Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002; 39:1151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15656/abstract/27\">",
"      Underwood SR, Bax JJ, vom Dahl J, et al. Imaging techniques for the assessment of myocardial hibernation. Report of a Study Group of the European Society of Cardiology. Eur Heart J 2004; 25:815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15656/abstract/28\">",
"      Smart SC, Knickelbine T, Stoiber TR, et al. Safety and accuracy of dobutamine-atropine stress echocardiography for the detection of residual stenosis of the infarct-related artery and multivessel disease during the first week after acute myocardial infarction. Circulation 1997; 95:1394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15656/abstract/29\">",
"      Bigi R, Cortigiani L, Desideri A, et al. Clinical and angiographic correlates of dobutamine-induced wall motion patterns after myocardial infarction. Am J Cardiol 2001; 88:944.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15656/abstract/30\">",
"      Leclercq F, Messner-Pellenc P, Moragues C, et al. Myocardial viability assessed by dobutamine echocardiography in acute myocardial infarction after successful primary coronary angioplasty. Am J Cardiol 1997; 80:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15656/abstract/31\">",
"      Afridi I, Qureshi U, Kopelen HA, et al. Serial changes in response of hibernating myocardium to inotropic stimulation after revascularization: a dobutamine echocardiographic study. J Am Coll Cardiol 1997; 30:1233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15656/abstract/32\">",
"      Lombardo A, Loperfido F, Trani C, et al. Contractile reserve of dysfunctional myocardium after revascularization: a dobutamine stress echocardiography study. J Am Coll Cardiol 1997; 30:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15656/abstract/33\">",
"      Nijland F, Kamp O, Verhorst PM, et al. In-hospital and long-term prognostic value of viable myocardium detected by dobutamine echocardiography early after acute myocardial infarction and its relation to indicators of left ventricular systolic dysfunction. Am J Cardiol 2001; 88:949.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15656/abstract/34\">",
"      Picano E, Sicari R, Landi P, et al. Prognostic value of myocardial viability in medically treated patients with global left ventricular dysfunction early after an acute uncomplicated myocardial infarction: a dobutamine stress echocardiographic study. Circulation 1998; 98:1078.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15656/abstract/35\">",
"      Pratali L, Picano E, Otasevic P, et al. Prognostic significance of the dobutamine echocardiography test in idiopathic dilated cardiomyopathy. Am J Cardiol 2001; 88:1374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15656/abstract/36\">",
"      Ramahi TM, Longo MD, Cadariu AR, et al. Dobutamine-induced augmentation of left ventricular ejection fraction predicts survival of heart failure patients with severe non-ischaemic cardiomyopathy. Eur Heart J 2001; 22:849.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15656/abstract/37\">",
"      Lu C, Carlino M, Fragasso G, et al. Enoximone echocardiography for predicting recovery of left ventricular dysfunction after revascularization : a novel test for detecting myocardial viability. Circulation 2000; 101:1255.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1528 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-202.43.93.2-49404BB9CF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_18_15656=[""].join("\n");
var outline_f15_18_15656=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12791804\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DOBUTAMINE STRESS ECHOCARDIOGRAPHY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Improvement in LV function after CABG",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Improvement in LV systolic function after percutaneous revascularization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Improvement in survival after revascularization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Use after MI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Use in LV dysfunction after MI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Comparison with perfusion imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Comparison with CMR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Role in idiopathic dilated cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      ENOXIMONE STRESS ECHOCARDIOGRAPHY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12791804\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/1528\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1528|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?43/11/44222\" title=\"algorithm 1\">",
"      Evaluation viable myocardium",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?39/41/40607\" title=\"algorithm 2\">",
"      Evaluation for hibernation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1528|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?10/24/10638\" title=\"figure 1\">",
"      Revasc hibernating myocardium",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/42/27309\" title=\"figure 2\">",
"      Dobut response outcome CABG",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?16/39/17022\" title=\"figure 3\">",
"      Noninvasive tech pred accuracy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?43/30/44526\" title=\"figure 4\">",
"      Techniques myocardial viability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1528|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?27/52/28491\" title=\"table 1\">",
"      Myocardial states LV dysfunct",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?24/56/25483\" title=\"table 2\">",
"      Diagnostic testing hibernation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/35/8759?source=related_link\">",
"      Clinical syndromes of stunned or hibernating myocardium",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/3/34874?source=related_link\">",
"      Clinical utility of cardiovascular magnetic resonance imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/3/24633?source=related_link\">",
"      Diagnosis and management of ischemic cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/41/10905?source=related_link\">",
"      Evaluation of hibernating myocardium",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/63/38906?source=related_link\">",
"      Overview of the therapy of heart failure due to systolic dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?24/13/24787?source=related_link\">",
"      Patient information: Echocardiogram (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/48/33546?source=related_link\">",
"      Predictors of survival in heart failure due to systolic dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/31/35319?source=related_link\">",
"      Protocols for stress echocardiography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/5/41048?source=related_link\">",
"      Stress echocardiography: Indications, imaging techniques and safety",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f15_18_15657="Callus new";
var content_f15_18_15657=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F86486%7EDERM%2F87626&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F86486%7EDERM%2F87626&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Callus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 405px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 596px\">",
"   <div class=\"ttl\">",
"    Callus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 576px; height: 433px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Large, hyperkeratotic area localized at the base of the third toe.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_18_15657=[""].join("\n");
var outline_f15_18_15657=null;
var title_f15_18_15658="Initial evaluation and staging of non-Hodgkin lymphoma";
var content_f15_18_15658=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Initial evaluation and staging of non-Hodgkin lymphoma",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/18/15658/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/18/15658/contributors\">",
"     Arnold S Freedman, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/18/15658/contributors\">",
"     Jonathan W Friedberg, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/18/15658/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/18/15658/contributors\">",
"     Andrew Lister, MD, FRCP, FRCPath, FRCR",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/18/15658/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/18/15658/contributors\">",
"     Rebecca F Connor, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?15/18/15658/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 2, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial evaluation of the patient with newly diagnosed non-Hodgkin lymphoma (NHL) must establish the precise histologic subtype, the extent and sites of disease (localized or advanced; nodal or extranodal), and the general health status of the patient. These studies help to determine the appropriate therapy and the patient's prognosis.",
"   </p>",
"   <p>",
"    A general review of the initial laboratory studies, imaging studies, staging, and prognosis of NHL will be presented here. Of note, the appropriate pretreatment evaluation differs by histologic subtype. As such, details regarding the pretreatment evaluation of many NHL histologies are presented separately as part of the discussion of their initial treatment. The clinical presentation and basic diagnostic tests are presented separately as well. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/61/27610?source=see_link\">",
"     \"Clinical presentation and diagnosis of non-Hodgkin lymphoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1150653658\">",
"    <span class=\"h1\">",
"     INITIAL LABORATORY STUDIES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;After the initial tissue biopsy provides a diagnosis of NHL, the following baseline laboratory tests are appropriate for most histologies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Complete blood count, white blood cell differential, platelet count, and examination of the peripheral smear for the presence of atypical cells, suggesting peripheral blood and bone marrow involvement",
"     </li>",
"     <li>",
"      Biochemical tests including blood urea nitrogen (BUN), creatinine, alkaline phosphatase, aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase (LDH), and albumin",
"     </li>",
"     <li>",
"      Serum calcium, electrolytes, and uric acid",
"     </li>",
"     <li>",
"      Serum protein electrophoresis",
"     </li>",
"     <li>",
"      HIV, hepatitis B and C serology",
"     </li>",
"     <li>",
"      Beta-2 microglobulin levels (in patients with indolent lymphomas)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These tests may not only contribute to staging but also influence the type of therapy chosen and its timing, and guide further investigations to other potential sites of disease or complications (eg, presence of viral hepatitis). Specific examples are discussed below:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1150653623\">",
"    <span class=\"h2\">",
"     CBC and peripheral smear",
"    </span>",
"    &nbsp;&mdash;&nbsp;All patients should have a complete blood count with white blood cell differential and an evaluation of their peripheral smear. Abnormalities of the complete blood count (CBC) are seen in approximately 60 percent of patients at the time of initial evaluation [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/1\">",
"     1",
"    </a>",
"    ]. In one study, anemia, thrombocytopenia, and leukopenia were noted in 42, 16, and 6 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/2\">",
"     2",
"    </a>",
"    ]. There appears to be a strong correlation between cytopenias and involvement of the bone marrow (BM) with NHL; BM involvement was identified by BM biopsy in 100, 69, 63, and 13 percent of patients with neutropenia or thrombocytopenia, leukopenia, anemia, or a normal CBC, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The presence of malignant cells in the peripheral blood is generally indicative of extensive marrow involvement and is seen in about 10 percent of all patients with NHL at diagnosis. It is most frequently seen in indolent lymphomas, occurring in 33 and 100 percent of patients with follicular lymphoma and chronic lymphocytic leukemia (CLL), respectively (",
"    <a class=\"graphic graphic_picture graphicRef65023 \" href=\"UTD.htm?23/54/24416\">",
"     picture 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/3\">",
"     3",
"    </a>",
"    ]. Flow cytometry of the peripheral blood can confirm the presence of circulating lymphoma cells.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Bone marrow aspiration and biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Practically all patients with NHL should undergo a bone marrow (BM) aspiration and biopsy prior to the initiation of treatment as part of their staging evaluation. It remains controversial whether patients require bilateral or unilateral BM biopsies. Overall, morphologic bone marrow (BM) involvement occurs in 30 to 50 percent of all patients with NHL, most commonly in the indolent histologies [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. Depending upon the subtype of NHL, evaluation of the bone marrow may include special stains, flow cytometry,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    genetics.",
"   </p>",
"   <p>",
"    In a study of 176 patients with NHL, among the 57 patients with indolent disease, 12 and 44 percent had unilateral and bilateral BM involvement, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. Among the 112 patients with aggressive histologies, involvement was unilateral or bilateral in 5 and 8 percent, respectively.",
"   </p>",
"   <p>",
"    Although bilateral biopsies increase the diagnostic yield by as much as 26 percent, this difference may not be therapeutically important [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/8\">",
"     8",
"    </a>",
"    ]. As an example, one study reported that the second BM biopsy resulted in a change of disease stage in only 6 and 2.5 percent of those with indolent or aggressive NHL, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/9\">",
"     9",
"    </a>",
"    ]. Thus, performing bilateral biopsies had a limited effect on upstaging most patients with either indolent or aggressive histologies from stage",
"    <span class=\"nowrap\">",
"     I/II",
"    </span>",
"    to stage IV [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/10\">",
"     10",
"    </a>",
"    ]. This issue may be obviated to some extent by obtaining a longer bone marrow biopsy specimen. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/22/5482?source=see_link&amp;anchor=H12#H12\">",
"     \"Bone marrow aspiration and biopsy: Indications and technique\", section on 'Adequacy of the biopsy specimen'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Renal function studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laboratory studies to assess renal function and risk of developing renal disease include the blood urea nitrogen (BUN), creatinine, and uric acid concentration. Although clinical evidence of renal involvement with lymphoma is only seen in 2 to 14 percent of all patients, an elevated serum creatinine is reported in 26 to 56 percent. Of importance, an elevated BUN or creatinine level may indicate bilateral ureteral obstruction secondary to massive enlargement of retroperitoneal nodes. This testing is also important as a guide to treatment, since many chemotherapeutic agents are nephrotoxic",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    excreted through the kidney (",
"    <a class=\"graphic graphic_table graphicRef54722 \" href=\"UTD.htm?28/4/28749\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/40/4744?source=see_link&amp;anchor=H11884942#H11884942\">",
"     \"Overview of renal disease associated with malignancy\", section on 'Tumor infiltration'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/48/41738?source=see_link\">",
"     \"Chemotherapy-related nephrotoxicity and dose modification in patients with renal insufficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is of critical importance to determine the serum uric acid concentration before treatment has begun both to evaluate for spontaneous tumor lysis syndrome and to serve as a baseline for following uric acid levels during treatment. High levels require attention before chemotherapy can be safely given, especially when there is the possibility of a rapid reduction in tumor mass following chemotherapy (ie, tumor lysis syndrome). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/57/27541?source=see_link\">",
"     \"Uric acid renal diseases\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/1/19481?source=see_link\">",
"     \"Tumor lysis syndrome: Definition, pathogenesis, clinical manifestations, etiology and risk factors\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Immunoglobulin studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immunoglobulin studies are of particular importance in certain NHL histologies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In patients with chronic lymphocytic",
"      <span class=\"nowrap\">",
"       leukemia/small",
"      </span>",
"      lymphocytic lymphoma, a pretreatment serum protein electrophoresis is useful to document a circulating monoclonal paraprotein or hypogammaglobulinemia; the latter may place the patient at increased risk for infection. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/58/10154?source=see_link\">",
"       \"Recognition of monoclonal proteins\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/6/24680?source=see_link\">",
"       \"Epidemiology and clinical manifestations of chronic lymphocytic leukemia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients with lymphoplasmacytic",
"      <span class=\"nowrap\">",
"       lymphoma/Waldenstrom",
"      </span>",
"      macroglobulinemia may have a serum IgM paraprotein that can result in symptoms of hyperviscosity necessitating emergent treatment. In addition, serum viscosity should be evaluated in patients with lymphoplasmacytic lymphoma and an elevated serum IgM paraprotein and in patients with symptoms suspicious of hyperviscosity. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/47/762?source=see_link&amp;anchor=H7#H7\">",
"       \"Epidemiology, pathogenesis, clinical manifestations and diagnosis of Waldenstr&ouml;m macroglobulinemia\", section on 'Hyperviscosity syndrome'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Other tumor markers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serum beta-2 microglobulin and lactate dehydrogenase (LDH) have prognostic significance in some histologic subtypes of NHL.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The serum beta-2 microglobulin level is useful in patients with multiple myeloma, chronic lymphocytic leukemia, follicular lymphoma, and other indolent lymphomas, where it has been used for prognostic purposes, as a surrogate measure of disease volume, and for monitoring response to therapy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/23/10618?source=see_link\">",
"       \"Staging and prognostic studies in multiple myeloma\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/6/15466?source=see_link\">",
"       \"Staging and prognosis of chronic lymphocytic leukemia\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/46/25322?source=see_link&amp;anchor=H75814042#H75814042\">",
"       \"Clinical manifestations, pathologic features, diagnosis, and prognosis of follicular lymphoma\", section on 'Follicular lymphoma IPI (FLIPI)'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Serum concentrations of LDH have been identified as an important independent predictor of survival in NHL [",
"      <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/11\">",
"       11",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/28/29127?source=see_link&amp;anchor=H17219017#H17219017\">",
"       \"Prognosis of diffuse large B cell lymphoma\", section on 'International Prognostic Index'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Lumbar puncture",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with highly aggressive NHL (Burkitt lymphoma, adult T cell leukemia-lymphoma, precursor T or B lymphoblastic",
"    <span class=\"nowrap\">",
"     leukemia/lymphoma),",
"    </span>",
"    human immunodeficiency virus (HIV)-positive NHL, or aggressive lymphoma (diffuse large B cell lymphoma, peripheral T cell lymphoma, grade IIIb follicular lymphoma, mantle cell lymphoma) who have epidural, bone marrow, testicular, or paranasal sinus involvement, or at least two extranodal disease sites are at risk of having central nervous system (CNS) involvement (",
"    <a class=\"graphic graphic_table graphicRef54470 \" href=\"UTD.htm?12/35/12859\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/12\">",
"     12",
"    </a>",
"    ]. Such patients should undergo examination of the cerebrospinal fluid (CSF) by lumbar puncture. If performed, cerebrospinal fluid should be sent for both cytology and flow cytometry. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/17/39194?source=see_link\">",
"     \"Secondary involvement of the central nervous system by non-Hodgkin lymphoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/6/19561?source=see_link\">",
"     \"Lumbar puncture: Technique; indications; contraindications; and complications in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     HIV serologies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Systemic NHL and primary CNS lymphoma are AIDS-defining malignancies. Approximately 25 to 40 percent of HIV-1 seropositive patients eventually develop a malignancy that, in about 10 percent of cases, is NHL. Compared with non-HIV-infected patients, seropositivity for HIV-1 increases the risk of development of a lymphoma approximately 100-fold over that of the seronegative population. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/36/20042?source=see_link\">",
"     \"AIDS-related lymphomas: Epidemiology, risk factors, and pathobiology\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most of the epidemiologic data has addressed the incidence of lymphoma in HIV positive patients. A paucity of data exists concerning the incidence of HIV infection among patients presenting with lymphoma and this can be expected to vary among populations. One study found that approximately 12 percent of patients with newly diagnosed NHL were HIV positive [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    All patients with newly diagnosed lymphoma should be asked about HIV risk factors. If risk factors are present, patients should undergo serologic testing for HIV. Some clinicians perform serologic testing for HIV in all patients with certain NHL subtypes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Hepatitis B and C serology",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of Hepatitis B surface antigen (HBsAg) positivity is increased in patients with hematologic malignancies and varies geographically. As an example, the prevalence is 1, 3.5, 5, and 10 percent in the United States, Western Europe, Turkey, and China, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Reactivation of hepatitis B virus during chemotherapy, which can be associated with a high mortality despite anti-viral treatment, occurs in 20 to 50 percent of HBsAg carriers [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. Screening for hepatitis B infection (eg, hepatitis B surface antigen and hepatitis B core antibody) should be considered at the time of lymphoma diagnosis to allow for prophylactic anti-viral therapy in infected patients starting before and continuing for a number of months after chemotherapy [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. Those not infected may benefit from hepatitis B vaccination. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/25/26009?source=see_link\">",
"     \"Hepatitis B virus reactivation associated with immunosuppression\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hepatitis B and hepatitis C may have a causal relationship with NHL [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/20-26\">",
"     20-26",
"    </a>",
"    ]. Hematologic and hepatic complications of these infections can affect treatment of NHL [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/27\">",
"     27",
"    </a>",
"    ]. It is for this reason that we recommend that physicians consider testing for both Hepatitis B and Hepatitis C in patients with newly diagnosed NHL [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/28\">",
"     28",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/2/44074?source=see_link&amp;anchor=H10#H10\">",
"     \"Chemotherapy hepatotoxicity and dose modification in patients with liver disease\", section on 'Hepatitis C'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Fertility preservation",
"    </span>",
"    &nbsp;&mdash;&nbsp;An overall discussion of fertility issues should be undertaken in patients of childbearing age prior to the initiation of treatment, including the possibility of sperm or fertilized ovum banking. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/7/38010?source=see_link\">",
"     \"Fertility preservation in patients undergoing gonadotoxic treatment or gonadal resection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     ROUTINE IMAGING STUDIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Routine radiologic studies in NHL should include contrast enhanced computerized tomographic (CT) imaging of the chest, abdomen, and pelvis. This CT both serves to help determine disease stage at diagnosis and to provide a baseline study for comparison to determine response to treatment. Integrated positron emissions tomography",
"    <span class=\"nowrap\">",
"     (PET)/CT",
"    </span>",
"    scanning is more sensitive and specific than CT in certain histologic subtypes of NHL; however, the fluorodeoxyglucose (FDG) avidity varies by NHL type making it a useful test in the initial evaluation of some (ie, diffuse large B cell lymphoma and Hodgkin lymphoma), but not all NHL [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/29\">",
"     29",
"    </a>",
"    ]. A chest radiograph is performed if CT is not available. Additional tests may be helpful in the evaluation of specific disease sites. (See",
"    <a class=\"local\" href=\"#H18\">",
"     'Consensus opinion'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H19\">",
"     'Evaluation of specific sites'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     CT scanning",
"    </span>",
"    &nbsp;&mdash;&nbsp;Contrast enhanced CT scanning of the chest, abdomen and pelvis is the imaging modality of choice for the initial evaluation of patients with NHL (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef59628 \" href=\"UTD.htm?38/32/39427\">",
"     image 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef58932 \" href=\"UTD.htm?3/43/3764\">",
"     image 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Typical radiographic findings of lung involvement in NHL include alveolar opacities (consolidation, masses, or nodules) and peribronchial disease. Other thoracic findings include chest wall, pleural, and pericardial involvement. In contrast to patients with HL, parenchymal lung lesions can be seen with no evidence of mediastinal or hilar lymphadenopathy. A study of 181 patients with NHL comparing staging via routine chest radiographs versus chest CT scanning found that the stage was affected in 8.8 percent of patients; however, this did not alter initial therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/30,31\">",
"     30,31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     PET scanning",
"    </span>",
"    &nbsp;&mdash;&nbsp;Positron emission tomographic (PET) scanning using 18F-fluorodeoxyglucose (18F-FDG) can be performed as an independent study or can be fused with a near-simultaneous CT scan into a single image (ie, integrated",
"    <span class=\"nowrap\">",
"     PET/CT",
"    </span>",
"    imaging). Integrated",
"    <span class=\"nowrap\">",
"     PET/CT",
"    </span>",
"    is generally preferred, when available, because it allows for more exact anatomic localization of abnormal isotope (ie, 18F-FDG) uptake. In addition, for typically FDG-avid tumors, integrated",
"    <span class=\"nowrap\">",
"     PET/CT",
"    </span>",
"    scanning results in more accurate staging than CT alone, PET alone, or PET read alongside with CT [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/32-36\">",
"     32-36",
"    </a>",
"    ]. A positive PET scan is determined visually by comparing the intensity of the suspected area of malignancy to the intensity of activity in the mediastinal blood pool [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Initial evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;In general, PET scanning reliably detects the aggressive and highly aggressive NHL variants as well as most Hodgkin lymphoma subtypes, while its overall usefulness in the indolent lymphomas remains unclear [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/37-43\">",
"     37-43",
"    </a>",
"    ]. However, the emergence of foci of intense uptake in a patient with an indolent NHL variant should raise suspicion of histologic transformation to a more aggressive NHL variant [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/37\">",
"     37",
"    </a>",
"    ]. PET appears to be highly sensitive and specific for detecting NHL in nodal and extranodal sites [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/44,45\">",
"     44,45",
"    </a>",
"    ], although its reliability for detection of bone marrow involvement has been questioned [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/46,47\">",
"     46,47",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/19/5433?source=see_link\">",
"     \"Pathobiology and treatment of histologic transformation in the indolent non-Hodgkin lymphomas\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one study, PET scanning detected disease in at least one location in 98 to 100 percent of patients with pathologically proven diffuse large B-cell lymphoma, mantle cell lymphoma, Hodgkin lymphoma, and follicular lymphoma, but was less often able to detect disease in patients with marginal zone and peripheral T-cell lymphoma [",
"      <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/47\">",
"       47",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a second study, using CT",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      magnetic resonance imaging (MRI) to confirm sites of involvement, PET identified &gt;97 percent of disease sites identified by CT or MRI in Hodgkin lymphoma and aggressive or highly aggressive NHL [",
"      <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/42\">",
"       42",
"      </a>",
"      ]. PET was less sensitive for the detection of lesions in the indolent NHL variants, with sensitivities of 91, 82, and 50 percent for follicular lymphoma, extranodal MZL of MALT tissue, and small lymphocytic",
"      <span class=\"nowrap\">",
"       lymphoma/splenic",
"      </span>",
"      MZL, respectively.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Recommendations regarding the use of PET scanning in the initial evaluation of NHL vary by histologic subtype. (See",
"    <a class=\"local\" href=\"#H18\">",
"     'Consensus opinion'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Evaluating response to treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Numerous studies have documented that PET scanning detects actively metabolizing tumor in residual masses following or during chemotherapy, and that persistent abnormal uptake predicts for early relapse",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    reduced survival [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/48-55\">",
"     48-55",
"    </a>",
"    ]. Examples of this observation are presented below:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one study, 90 patients with newly diagnosed aggressive NHL were prospectively explored with PET prior to, after two cycles, and following completion of chemotherapy [",
"      <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/56\">",
"       56",
"      </a>",
"      ]. Patients achieving PET-negative status after two cycles of chemotherapy, in comparison to those who were PET-positive at this same time period, had a significantly higher rate of complete remission (83 versus 58 percent) and greater estimated two-year overall survival (90 versus 61 percent). Results from other studies have been mixed with some concluding that a positive early interim PET scan is a strong and independent predictor of disease progression [",
"      <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/57,58\">",
"       57,58",
"      </a>",
"      ] and others not finding such a correlation [",
"      <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/59\">",
"       59",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Although an interim PET scan may have prognostic value, there are concerns about the reproducibility of PET scan interpretation and at this time, no prospectively validated criteria for interim PET scan interpretation. A review of positive interim PET scans from the Eastern Cooperative Oncology Group (ECOG) trial E3404 showed only moderate reproducibility between three expert nuclear medicine physicians [",
"      <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/60\">",
"       60",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Following completion of treatment, some patients with NHL may have residual masses on CT scanning containing only fibrotic tissue or non-viable tumor. Such patients may be erroneously considered as not having achieved complete remission (",
"      <a class=\"graphic graphic_table graphicRef64921 \" href=\"UTD.htm?29/27/30140\">",
"       table 3",
"      </a>",
"      ). Functional imaging of these sites using PET scanning or combined",
"      <span class=\"nowrap\">",
"       PET/CT",
"      </span>",
"      scanning appears to be able to resolve these issues in most cases [",
"      <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/61,62\">",
"       61,62",
"      </a>",
"      ]. However, PET-positive disease at the completion of treatment requires a tissue biopsy or further evaluation, as some of these patients remain in prolonged remission.",
"     </li>",
"     <li>",
"      In several studies, PET was used to assess the degree of response of aggressive lymphoma to salvage chemotherapy in patients prior to hematopoietic cell transplantation [",
"      <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/63-65\">",
"       63-65",
"      </a>",
"      ]. As an example, one of these studies with a median follow-up of four years reported that complete remission was maintained in 83 versus 13 percent of patients with a negative or positive pre-transplantation PET study, respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/63\">",
"       63",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Integrated",
"    <span class=\"nowrap\">",
"     PET/CT",
"    </span>",
"    scanning improves the accuracy of determining treatment response in patients with typically FDG-avid lymphomas and has been incorporated into the International Workshop Criteria of treatment response (",
"    <a class=\"graphic graphic_table graphicRef64921 \" href=\"UTD.htm?29/27/30140\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/66\">",
"     66",
"    </a>",
"    ]. Its effect on the prognostic value of the International Prognostic Index (",
"    <a class=\"graphic graphic_table graphicRef70850 \" href=\"UTD.htm?17/21/17757\">",
"     table 4",
"    </a>",
"    ) is unknown [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/67\">",
"     67",
"    </a>",
"    ] and there is no evidence that the results of routine scanning outside of clinical trials can be successfully used to alter treatment with an improvement in outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/68-70\">",
"     68-70",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Consensus opinion",
"    </span>",
"    &nbsp;&mdash;&nbsp;An International Harmonization Project was convened to discuss standardization of PET scanning in lymphoma. We agree with the following conclusions, which were presented in a 2007 report [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/29\">",
"     29",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      PET scanning",
"      <strong>",
"       before",
"      </strong>",
"      treatment is recommended only for those lymphomas that are routinely avid for labeled glucose (eg, diffuse large B cell lymphoma, Hodgkin lymphoma) [",
"      <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/71\">",
"       71",
"      </a>",
"      ]. There is not sufficient evidence in support of the use of PET scanning for other lymphoma subtypes.",
"     </li>",
"     <li>",
"      Use of PET for treatment monitoring",
"      <strong>",
"       during",
"      </strong>",
"      a course of therapy should only be done as part of a clinical trial or as part of a prospective registry.",
"     </li>",
"     <li>",
"      PET scanning",
"      <strong>",
"       after",
"      </strong>",
"      completion of therapy should be performed at least three weeks and preferably at six to eight weeks after chemotherapy or chemo-immunotherapy and 8 to 12 weeks after radiation or chemoradiotherapy.",
"     </li>",
"     <li>",
"      Mediastinal blood pool activity is recommended as the reference background activity to define PET positivity for a residual mass &ge;2 cm in greatest transverse diameter, regardless of location.",
"     </li>",
"     <li>",
"      A smaller residual mass or a normal sized lymph node (ie, &le;1 x 1 cm in diameter) should be considered positive if its activity is above that of the surrounding background.",
"     </li>",
"     <li>",
"      There is NO role for the use of PET to follow patients in remission.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     EVALUATION OF SPECIFIC SITES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Specific evaluation of the gastrointestinal tract, liver, spleen, central nervous system, skeleton, or genitourinary tract is reserved for patients with symptoms or those at particularly high risk for involvement of these sites.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Gastrointestinal tract",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gastrointestinal (GI) tract involvement is seen in 10 to 60 percent of patients with NHL, with the majority of primary extranodal NHLs arising in the GI tract. In addition, up to 20 percent of patients with involvement of Waldeyer's ring (tonsils, base of the tongue, nasopharynx) also have involvement of the GI tract [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/72-74\">",
"     72-74",
"    </a>",
"    ]. Evaluation of the GI tract with contrast studies or endoscopy is indicated for patients with involvement of Waldeyer's ring, those with symptoms of GI involvement, and for patients with mantle cell lymphoma (",
"    <a class=\"graphic graphic_table graphicRef68593 \" href=\"UTD.htm?30/61/31708\">",
"     table 5",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/32/8714?source=see_link&amp;anchor=H9#H9\">",
"     \"Clinical presentation and diagnosis of primary gastrointestinal lymphomas\", section on 'Diagnostic evaluation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/63/17402?source=see_link&amp;anchor=H3#H3\">",
"     \"Initial treatment of mantle cell lymphoma\", section on 'Pretreatment evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Computed tomography (CT) (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef75825 \" href=\"UTD.htm?26/26/27055\">",
"     image 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef72998 \" href=\"UTD.htm?8/6/8290\">",
"     image 4",
"    </a>",
"    ) is useful for simultaneously evaluating mucosal lesions and assessing the extraluminal extent of lesions and associated adenopathy.",
"   </p>",
"   <p>",
"    Endoscopic procedures are extremely helpful in tumor localization and staging (eg, endoscopic ultrasound), detection of bleeding lesions, and in the obtaining of biopsy specimens in patients with GI lymphoma (",
"    <a class=\"graphic graphic_picture graphicRef69159 \" href=\"UTD.htm?32/60/33728\">",
"     picture 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef72196 \" href=\"UTD.htm?16/52/17231\">",
"     picture 3",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/32/8714?source=see_link\">",
"     \"Clinical presentation and diagnosis of primary gastrointestinal lymphomas\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Liver and spleen",
"    </span>",
"    &nbsp;&mdash;&nbsp;A percutaneous liver biopsy may be indicated if there are abnormalities on hepatic blood tests or liver scan in patients who would otherwise have been classified as having stage I disease. Although some advocate fine needle aspiration biopsy of the spleen under radiologic guidance, this is generally not recommended because of the increased risk of bleeding [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/75,76\">",
"     75,76",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Central nervous system",
"    </span>",
"    &nbsp;&mdash;&nbsp;Central nervous system (CNS) evaluation via magnetic resonance imaging (with and without gadolinium)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    lumbar puncture is indicated in patients with neurologic symptoms or signs (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef60130 \" href=\"UTD.htm?1/1/1043\">",
"     image 5",
"    </a>",
"    ). This combination of studies evaluates for both parenchymal and leptomeningeal involvement. CNS screening studies in patients without CNS symptoms or signs are generally reserved for those patients who are at high risk of CNS involvement. These include patients with bone marrow, testicular, or paranasal sinus involvement, or those with underlying immunodeficiency. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/6/19561?source=see_link\">",
"     \"Lumbar puncture: Technique; indications; contraindications; and complications in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/17/39194?source=see_link&amp;anchor=H6052480#H6052480\">",
"     \"Secondary involvement of the central nervous system by non-Hodgkin lymphoma\", section on 'Neuroimaging'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Skeletal imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Imaging of the bones with plain films, CT,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    MRI is not routinely performed in NHL, but is indicated in the presence of bony pain",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    suspicion of a pathologic fracture. Bone lesions in NHL are mostly osteolytic on plain films, in contrast to those in patients with Hodgkin lymphoma, which are predominantly osteoblastic (",
"    <a class=\"graphic graphic_table graphicRef54124 \" href=\"UTD.htm?21/17/21787\">",
"     table 6",
"    </a>",
"    ). If there is suspicion of spinal cord compression, urgent MRI of the entire spinal column is indicated, since multiple sites may be involved. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/27/6585?source=see_link&amp;anchor=H14#H14\">",
"     \"Clinical features and diagnosis of neoplastic epidural spinal cord compression, including cauda equina syndrome\", section on 'Radiologic confirmation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Genitourinary tract",
"    </span>",
"    &nbsp;&mdash;&nbsp;The genitourinary (GU) tract (eg, kidney, testis, ovary) is involved in approximately 10 percent of patients at initial diagnosis. While most lesions will be detected on CT scan, testicular ultrasound is indicated for patients with an abnormality on testicular examination.",
"   </p>",
"   <p>",
"    The most common site of GU involvement is the kidney, usually in patients with aggressive and highly aggressive histologic subtypes. Renal involvement is often seen on CT as multiple discrete masses, or diffuse infiltration causing renal enlargement (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef81101 \" href=\"UTD.htm?12/59/13233\">",
"     image 6",
"    </a>",
"    ). Isolated masses are less common.",
"   </p>",
"   <p>",
"    The next most common sites of GU involvement are the testis or ovary, usually in patients with diffuse large B-cell NHL. Testicular involvement is best evaluated by ultrasound (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef50490 \" href=\"UTD.htm?22/1/22544\">",
"     image 7",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/77-79\">",
"     77-79",
"    </a>",
"    ]. Other organs less commonly affected include the bladder or ureter with mural thickening, as well as the uterus, cervix, and prostate with mass lesions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     FUNCTIONAL TESTING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with NHL should undergo functional testing of their heart and lungs prior to the administration of chemotherapy or radiation therapy that may affect these organs. In addition, all patients should be evaluated for their performance status before, during, and after treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Cardiac function",
"    </span>",
"    &nbsp;&mdash;&nbsp;Baseline evaluation of cardiac function (eg, cardiac ejection fraction) should be considered if the patient is likely to be treated with an anthracycline or mediastinal irradiation. Cardiac function testing may not be necessary if the patient is young, has no history of heart disease, and is going to get a relatively small dose of an anthracycline. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/46/41706?source=see_link&amp;anchor=H26#H26\">",
"     \"Cardiotoxicity of anthracycline-like chemotherapy agents\", section on 'Noninvasive monitoring of LVEF'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Pulmonary function",
"    </span>",
"    &nbsp;&mdash;&nbsp;While pulmonary function studies (PFTs; eg, diffusing capacity for carbon monoxide) obtained at diagnosis do not appear to predict",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/15/39159?source=see_link\">",
"     bleomycin",
"    </a>",
"    lung toxicity, we obtain baseline PFTs if the patient is to be treated with bleomycin. This allows for the quantification of any change in pulmonary function during or after treatment. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/49/20250?source=see_link&amp;anchor=H3#H3\">",
"     \"Treatment-related toxicity in men with testicular germ cell tumors\", section on 'Pulmonary'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/31/12794?source=see_link\">",
"     \"Bleomycin-induced lung injury\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Performance status",
"    </span>",
"    &nbsp;&mdash;&nbsp;Performance status is a measure of a patient's functional capacity that can predict survival in patients with cancer and is used as an entry criterion and an adjustment factor for clinical trials of anticancer therapies. A number of metrics have been developed to quantify performance status; among them, the Karnofsky performance status (KPS) and the Eastern Cooperative Oncology Group (ECOG) performance status are the most commonly used (",
"    <a class=\"graphic graphic_table graphicRef58785 graphicRef72901 \" href=\"UTD.htm?43/16/44300\">",
"     table 7A-B",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     STAGING",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Ann Arbor staging system with Cotswold modification, originally developed Hodgkin lymphoma, has been adapted for staging NHL [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/80,81\">",
"     80,81",
"    </a>",
"    ]. This staging system focuses on the number of tumor sites (nodal and extranodal), location, and the presence or absence of systemic (\"B\") symptoms (",
"    <a class=\"graphic graphic_table graphicRef73699 \" href=\"UTD.htm?36/59/37819\">",
"     table 8",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/61/27610?source=see_link&amp;anchor=H10#H10\">",
"     \"Clinical presentation and diagnosis of non-Hodgkin lymphoma\", section on 'Systemic complaints (B symptoms)'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Stage I refers to NHL involving a single lymph node region (stage I) or a single extralymphatic organ or site (stage IE) (",
"      <a class=\"graphic graphic_figure graphicRef55422 \" href=\"UTD.htm?41/2/42021\">",
"       figure 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Stage II refers to two or more involved lymph node regions on the same side of the diaphragm (stage II) or with localized involvement of an extralymphatic organ or site (stage IIE).",
"     </li>",
"     <li>",
"      Stage III refers to lymph node involvement on both sides of the diaphragm (stage III), or with localized involvement of an extralymphatic organ or site (stage IIIE) or spleen (stage IIIS), or both (stage IIIES).",
"     </li>",
"     <li>",
"      Stage IV refers to the presence of diffuse or disseminated involvement of one or more extralymphatic organs (eg, liver, bone marrow, lung), with or without associated lymph node involvement.",
"     </li>",
"     <li>",
"      The presence or absence of systemic symptoms should be noted with each stage designation. (A = asymptomatic; B = presence of fever (&gt;38 degrees C), sweats, or weight loss &gt;10 percent of body weight over six months.) (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/61/27610?source=see_link&amp;anchor=H10#H10\">",
"       \"Clinical presentation and diagnosis of non-Hodgkin lymphoma\", section on 'Systemic complaints (B symptoms)'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Since NHLs most frequently disseminate hematogenously, this staging system has proven to be much less useful than for Hodgkin lymphoma, which disseminates principally by contiguous lymphatic extension. As an example, only 10 percent of patients with follicular lymphoma have localized disease at diagnosis (ie, stage I), and the majority of patients with aggressive lymphomas have advanced stage disease (ie, stage",
"    <span class=\"nowrap\">",
"     III/IV)",
"    </span>",
"    at presentation [",
"    <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/82\">",
"     82",
"    </a>",
"    ]. It is generally accepted that there is little therapeutic benefit in distinguishing between stages III and IV disease in NHL, since treatment options are nearly identical.",
"   </p>",
"   <p>",
"    Thus, staging is undertaken in NHLs to identify the small numbers of patients with \"early stage disease\" who can be treated with local therapy or combined modality treatment, and to stratify within histologic subtypes in order to determine prognosis and assess the impact of treatment (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/28/29127?source=see_link&amp;anchor=H17219045#H17219045\">",
"     \"Prognosis of diffuse large B cell lymphoma\", section on 'Stage adjusted IPI'",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H334141054\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple studies have demonstrated that prognosis of NHL is far more dependent upon histopathology, being only secondarily influenced by clinical parameters including age, presence of extranodal disease, performance status, and stage",
"    <span class=\"nowrap\">",
"     (I/II",
"    </span>",
"    versus",
"    <span class=\"nowrap\">",
"     III/IV).",
"    </span>",
"    Since stage usually depends only upon the location and number of disease sites, it is not a true measure of tumor burden, which is clearly an important prognostic determinant in NHL, and may also affect the overall treatment program employed (eg, use of adjuvant radiotherapy to sites of bulky disease).",
"   </p>",
"   <p>",
"    The determination of prognosis for each of the NHL variants is known to be related to the multiple differences in tumor cell biology (eg, cytogenetics, immunophenotype, growth fraction, cytokine production) found within each of the specific disease variants. It is therefore likely that prognostic indicators in the NHLs will take three semi-independent formats:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A general prognostic score with value in all of the NHL variants, such as the International Prognostic Index (IPI) (",
"      <a class=\"graphic graphic_table graphicRef70850 \" href=\"UTD.htm?17/21/17757\">",
"       table 4",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/28/29127?source=see_link&amp;anchor=H17219017#H17219017\">",
"       \"Prognosis of diffuse large B cell lymphoma\", section on 'International Prognostic Index'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A disease-specific prognostic score, with variables reflecting differences in tumor biology for each of the NHL variants, such as the Follicular lymphoma International Prognostic Index (FLIPI) (",
"      <a class=\"graphic graphic_table graphicRef55987 \" href=\"UTD.htm?36/23/37243\">",
"       table 9",
"      </a>",
"      ) and the",
"      <span class=\"nowrap\">",
"       NK/T",
"      </span>",
"      cell lymphoma prognostic index (",
"      <a class=\"graphic graphic_table graphicRef67924 \" href=\"UTD.htm?22/12/22732\">",
"       table 10",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/46/25322?source=see_link&amp;anchor=H75814042#H75814042\">",
"       \"Clinical manifestations, pathologic features, diagnosis, and prognosis of follicular lymphoma\", section on 'Follicular lymphoma IPI (FLIPI)'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A treatment-specific prognostic score, with variables reflecting interactions among patient, tumor, and the therapeutic regimen employed [",
"      <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/83\">",
"       83",
"      </a>",
"      ]. An example is gene expression profiling, which separates patients with diffuse large B-cell lymphoma into categories that are more or less likely to respond to treatment with CHOP-based therapy [",
"      <a class=\"abstract\" href=\"UTD.htm?15/18/15658/abstract/84\">",
"       84",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/28/29127?source=see_link&amp;anchor=H17219052#H17219052\">",
"       \"Prognosis of diffuse large B cell lymphoma\", section on 'Gene expression profiling'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Further discussion of prognosis can be found in the topics that discuss the specific histologies of NHL. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Diffuse large B cell lymphoma &mdash; (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/28/29127?source=see_link\">",
"       \"Prognosis of diffuse large B cell lymphoma\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Follicular lymphoma &mdash; (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/46/25322?source=see_link&amp;anchor=H28#H28\">",
"       \"Clinical manifestations, pathologic features, diagnosis, and prognosis of follicular lymphoma\", section on 'Prognosis'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Peripheral T cell lymphoma &mdash; (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/36/35400?source=see_link&amp;anchor=H17#H17\">",
"       \"Clinical manifestations, pathologic features, and diagnosis of peripheral T cell lymphoma, not otherwise specified\", section on 'Prognosis'",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?39/28/40386?source=see_link\">",
"       \"Patient information: Lymphoma (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?8/9/8339?source=see_link\">",
"       \"Patient information: Follicular lymphoma in adults (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?26/60/27588?source=see_link\">",
"       \"Patient information: Diffuse large B-cell lymphoma in adults (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H43\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The initial evaluation of the patient with suspected non-Hodgkin lymphoma (NHL) must establish the extent and sites of disease (localized or advanced; nodal or extranodal) (",
"      <a class=\"graphic graphic_table graphicRef73699 \" href=\"UTD.htm?36/59/37819\">",
"       table 8",
"      </a>",
"      ) and the performance status of the patient (",
"      <a class=\"graphic graphic_table graphicRef58785 graphicRef72901 \" href=\"UTD.htm?43/16/44300\">",
"       table 7A-B",
"      </a>",
"      ).The treatment approach and prognosis are strongly dependent upon this information.",
"     </li>",
"     <li>",
"      The initial workup should include a complete history, including past and present illnesses (eg, hepatitis B, C, HIV risk factors) as well as the presence or absence of systemic \"B\" symptoms. The physical examination should include emphasis on all node-bearing areas, including Waldeyer's ring, the liver, and spleen. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/61/27610?source=see_link\">",
"       \"Clinical presentation and diagnosis of non-Hodgkin lymphoma\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Initial laboratory tests and imaging studies should include, as a minimum (See",
"      <a class=\"local\" href=\"#H1150653658\">",
"       'Initial laboratory studies'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H13\">",
"       'Routine imaging studies'",
"      </a>",
"      above.):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Complete blood count, white cell differential, platelet count",
"     </li>",
"     <li>",
"      Tests of renal and hepatic function, including lactate dehydrogenase",
"     </li>",
"     <li>",
"      Testing for HIV, hepatitis B, and hepatitis C (in select patients)",
"     </li>",
"     <li>",
"      Electrolytes, uric acid",
"     </li>",
"     <li>",
"      Contrast-enhanced computed tomography scan of the chest, abdomen, and pelvis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Specific evaluation of the gastrointestinal tract, liver, spleen, central nervous system, skeleton, or genitourinary tract is reserved for patients with symptoms or those at particularly high risk for involvement of these sites. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Evaluation of specific sites'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A number of other studies and discussions with the patient need to be undertaken for the following issues:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Positron emission tomographic (PET) scanning, when used as part of initial staging, should be done in addition to, rather than in place of, computed tomography scanning. It is of particular value for the evaluation of aggressive variants of NHL and extranodal disease. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'PET scanning'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H18\">",
"       'Consensus opinion'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Baseline evaluation of cardiac function (eg, cardiac ejection fraction) should be considered if the patient is likely to be treated with an anthracycline or mediastinal irradiation. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/46/41706?source=see_link&amp;anchor=H26#H26\">",
"       \"Cardiotoxicity of anthracycline-like chemotherapy agents\", section on 'Noninvasive monitoring of LVEF'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Baseline pulmonary function studies (eg, diffusing capacity for carbon monoxide) should be obtained if the patient is to be treated with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/15/39159?source=see_link\">",
"       bleomycin",
"      </a>",
"      . (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/49/20250?source=see_link&amp;anchor=H3#H3\">",
"       \"Treatment-related toxicity in men with testicular germ cell tumors\", section on 'Pulmonary'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/31/12794?source=see_link\">",
"       \"Bleomycin-induced lung injury\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      An overall discussion of fertility issues should be undertaken in patients of childbearing age prior to the initiation of treatment, including the possibility of sperm or fertilized ovum banking. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/7/38010?source=see_link\">",
"       \"Fertility preservation in patients undergoing gonadotoxic treatment or gonadal resection\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      NHL is staged using the Ann Arbor staging system with Cotswold modification (",
"      <a class=\"graphic graphic_table graphicRef73699 \" href=\"UTD.htm?36/59/37819\">",
"       table 8",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H29\">",
"       'Staging'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/1\">",
"      Bloomfield CD, McKenna RW, Brunning RD. Significance of haematological parameters in the non-Hodgkin's malignant lymphomas. Br J Haematol 1976; 32:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/2\">",
"      Conlan MG, Armitage JO, Bast M, Weisenburger DD. Clinical significance of hematologic parameters in non-Hodgkin's lymphoma at diagnosis. Cancer 1991; 67:1389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/3\">",
"      McKenna RW, Bloomfield CD, Brunning RD. Nodular lymphoma: bone marrow and blood manifestations. Cancer 1975; 36:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/4\">",
"      Conlan MG, Bast M, Armitage JO, Weisenburger DD. Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group. J Clin Oncol 1990; 8:1163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/5\">",
"      Foucar K, McKenna RW, Frizzera G, Brunning RD. Bone marrow and blood involvement by lymphoma in relationship to the Lukes--Collins classification. Cancer 1982; 49:888.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/6\">",
"      Brunning RD, Bloomfield CD, McKenna RW, Peterson LA. Bilateral trephine bone marrow biopsies in lymphoma and other neoplastic diseases. Ann Intern Med 1975; 82:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/7\">",
"      Juneja SK, Wolf MM, Cooper IA. Value of bilateral bone marrow biopsy specimens in non-Hodgkin's lymphoma. J Clin Pathol 1990; 43:630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/8\">",
"      Menon NC, Buchanan JG. Bilateral trephine bone marrow biopsies in Hodgkin's and non-Hodgkin's lymphoma. Pathology 1979; 11:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/9\">",
"      Ebie N, Loew JM, Gregory SA. Bilateral trephine bone marrow biopsy for staging non-Hodgkin's lymphoma--a second look. Hematol Pathol 1989; 3:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/10\">",
"      Luoni M, Declich P, Fava S, et al. Bone marrow biopsy for the staging of non-Hodgkin's lymphoma: bilateral or unilateral trephine biopsy? Tumori 1995; 81:410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/11\">",
"      Dumontet C, Drai J, Bienvenu J, et al. Profiles and prognostic values of LDH isoenzymes in patients with non-Hodgkin's lymphoma. Leukemia 1999; 13:811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/12\">",
"      Hegde U, Filie A, Little RF, et al. High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology. Blood 2005; 105:496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/13\">",
"      D'Addario G, Dieterle A, Torhorst J, et al. HIV-testing and newly-diagnosed malignant lymphomas. The SAKK 96/90 registration study. Leuk Lymphoma 2003; 44:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/14\">",
"      Lau GK, Lee CK, Liang R. Hepatitis B virus infection and bone marrow transplantation. Crit Rev Oncol Hematol 1999; 31:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/15\">",
"      Takai S, Tsurumi H, Ando K, et al. Prevalence of hepatitis B and C virus infection in haematological malignancies and liver injury following chemotherapy. Eur J Haematol 2005; 74:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/16\">",
"      Lalazar G, Rund D, Shouval D. Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies. Br J Haematol 2007; 136:699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/17\">",
"      Aksoy S, Harputluoglu H, Kilickap S, et al. Rituximab-related viral infections in lymphoma patients. Leuk Lymphoma 2007; 48:1307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/18\">",
"      Artz AS, Somerfield MR, Feld JJ, et al. American Society of Clinical Oncology provisional clinical opinion: chronic hepatitis B virus infection screening in patients receiving cytotoxic chemotherapy for treatment of malignant diseases. J Clin Oncol 2010; 28:3199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/19\">",
"      Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology 2009; 50:661.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/20\">",
"      Viswanatha DS, Dogan A. Hepatitis C virus and lymphoma. J Clin Pathol 2007; 60:1378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/21\">",
"      Spinelli JJ, Lai AS, Krajden M, et al. Hepatitis C virus and risk of non-Hodgkin lymphoma in British Columbia, Canada. Int J Cancer 2008; 122:630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/22\">",
"      Sch&ouml;llkopf C, Smedby KE, Hjalgrim H, et al. Hepatitis C infection and risk of malignant lymphoma. Int J Cancer 2008; 122:1885.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/23\">",
"      Engels EA, Cho ER, Jee SH. Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study. Lancet Oncol 2010; 11:827.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/24\">",
"      Yeo W, Chan TC, Leung NW, et al. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab. J Clin Oncol 2009; 27:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/25\">",
"      Hsu C, Hsiung CA, Su IJ, et al. A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: a randomized trial. Hepatology 2008; 47:844.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/26\">",
"      Ya��ci M, Ya��ci M, Acar K, et al. A prospective study on chemotherapy-induced hepatitis B virus reactivation in chronic HBs Ag carriers with hematologic malignancies and pre-emptive therapy with nucleoside analogues. Leuk Lymphoma 2006; 47:1608.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/27\">",
"      Besson C, Canioni D, Lepage E, et al. Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte programs. J Clin Oncol 2006; 24:953.",
"     </a>",
"    </li>",
"    <li>",
"     National Comprehensive Cancer Network (NCCN) guidelines. Available at: www.nccn.org (Accessed on May 15, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/29\">",
"      Juweid ME, Stroobants S, Hoekstra OS, et al. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol 2007; 25:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/30\">",
"      North LB, Libshitz HI, Lorigan JG. Thoracic lymphoma. Radiol Clin North Am 1990; 28:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/31\">",
"      Castellino RA, Hilton S, O'Brien JP, Portlock CS. Non-Hodgkin lymphoma: contribution of chest CT in the initial staging evaluation. Radiology 1996; 199:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/32\">",
"      Allen-Auerbach M, Quon A, Weber WA, et al. Comparison between 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography and positron emission tomography/computed tomography hardware fusion for staging of patients with lymphoma. Mol Imaging Biol 2004; 6:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/33\">",
"      Schaefer NG, Hany TF, Taverna C, et al. Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging--do we need contrast-enhanced CT? Radiology 2004; 232:823.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/34\">",
"      Hernandez-Maraver D, Hernandez-Navarro F, Gomez-Leon N, et al. Positron emission tomography/computed tomography: diagnostic accuracy in lymphoma. Br J Haematol 2006; 135:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/35\">",
"      Kwee TC, Kwee RM, Nievelstein RA. Imaging in staging of malignant lymphoma: a systematic review. Blood 2008; 111:504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/36\">",
"      Freudenberg LS, Antoch G, Sch&uuml;tt P, et al. FDG-PET/CT in re-staging of patients with lymphoma. Eur J Nucl Med Mol Imaging 2004; 31:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/37\">",
"      Karam M, Novak L, Cyriac J, et al. Role of fluorine-18 fluoro-deoxyglucose positron emission tomography scan in the evaluation and follow-up of patients with low-grade lymphomas. Cancer 2006; 107:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/38\">",
"      Seam P, Juweid ME, Cheson BD. The role of FDG-PET scans in patients with lymphoma. Blood 2007; 110:3507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/39\">",
"      Kostakoglu L, Leonard JP, Kuji I, et al. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma. Cancer 2002; 94:879.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/40\">",
"      Wirth A, Seymour JF, Hicks RJ, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma. Am J Med 2002; 112:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/41\">",
"      Zijlstra JM, Hoekstra OS, Raijmakers PG, et al. 18FDG positron emission tomography versus 67Ga scintigraphy as prognostic test during chemotherapy for non-Hodgkin's lymphoma. Br J Haematol 2003; 123:454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/42\">",
"      Tsukamoto N, Kojima M, Hasegawa M, et al. The usefulness of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG-PET) and a comparison of (18)F-FDG-pet with (67)gallium scintigraphy in the evaluation of lymphoma: relation to histologic subtypes based on the World Health Organization classification. Cancer 2007; 110:652.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/43\">",
"      Feeney J, Horwitz S, G&ouml;nen M, Sch&ouml;der H. Characterization of T-cell lymphomas by FDG PET/CT. AJR Am J Roentgenol 2010; 195:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/44\">",
"      Isasi CR, Lu P, Blaufox MD. A metaanalysis of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography in the staging and restaging of patients with lymphoma. Cancer 2005; 104:1066.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/45\">",
"      de Jong PA, van Ufford HM, Baarslag HJ, et al. CT and 18F-FDG PET for noninvasive detection of splenic involvement in patients with malignant lymphoma. AJR Am J Roentgenol 2009; 192:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/46\">",
"      Carr R, Barrington SF, Madan B, et al. Detection of lymphoma in bone marrow by whole-body positron emission tomography. Blood 1998; 91:3340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/47\">",
"      Elstrom R, Guan L, Baker G, et al. Utility of FDG-PET scanning in lymphoma by WHO classification. Blood 2003; 101:3875.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/48\">",
"      Jerusalem G, Beguin Y, Fassotte MF, et al. Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging. Blood 1999; 94:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/49\">",
"      Naumann R, Vaic A, Beuthien-Baumann B, et al. Prognostic value of positron emission tomography in the evaluation of post-treatment residual mass in patients with Hodgkin's disease and non-Hodgkin's lymphoma. Br J Haematol 2001; 115:793.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/50\">",
"      Spaepen K, Stroobants S, Dupont P, et al. Early restaging positron emission tomography with ( 18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma. Ann Oncol 2002; 13:1356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/51\">",
"      Friedberg JW, Chengazi V. PET scans in the staging of lymphoma: current status. Oncologist 2003; 8:438.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/52\">",
"      Zinzani PL, Fanti S, Battista G, et al. Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients. Br J Cancer 2004; 91:850.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/53\">",
"      Svoboda J, Andreadis C, Elstrom R, et al. Prognostic value of FDG-PET scan imaging in lymphoma patients undergoing autologous stem cell transplantation. Bone Marrow Transplant 2006; 38:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/54\">",
"      Safar V, Dupuis J, Itti E, et al. Interim [18F]fluorodeoxyglucose positron emission tomography scan in diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy plus rituximab. J Clin Oncol 2012; 30:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/55\">",
"      Mato AR, Svoboda J, Feldman T, et al. Post-treatment (not interim) positron emission tomography-computed tomography scan status is highly predictive of outcome in mantle cell lymphoma patients treated with R-HyperCVAD. Cancer 2012; 118:3565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/56\">",
"      Haioun C, Itti E, Rahmouni A, et al. [18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome. Blood 2005; 106:1376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/57\">",
"      Hutchings M, Loft A, Hansen M, et al. FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma. Blood 2006; 107:52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/58\">",
"      Kostakoglu L, Goldsmith SJ, Leonard JP, et al. FDG-PET after 1 cycle of therapy predicts outcome in diffuse large cell lymphoma and classic Hodgkin disease. Cancer 2006; 107:2678.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/59\">",
"      Pregno P, Chiappella A, Bell&ograve; M, et al. Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP. Blood 2012; 119:2066.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/60\">",
"      Horning SJ, Juweid ME, Sch&ouml;der H, et al. Interim positron emission tomography scans in diffuse large B-cell lymphoma: an independent expert nuclear medicine evaluation of the Eastern Cooperative Oncology Group E3404 study. Blood 2010; 115:775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/61\">",
"      Spaepen K, Stroobants S, Dupont P, et al. Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods? J Clin Oncol 2001; 19:414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/62\">",
"      Gawande RS, Khurana A, Messing S, et al. Differentiation of normal thymus from anterior mediastinal lymphoma and lymphoma recurrence at pediatric PET/CT. Radiology 2012; 262:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/63\">",
"      Spaepen K, Stroobants S, Dupont P, et al. Prognostic value of pretransplantation positron emission tomography using fluorine 18-fluorodeoxyglucose in patients with aggressive lymphoma treated with high-dose chemotherapy and stem cell transplantation. Blood 2003; 102:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/64\">",
"      Schot B, van Imhoff G, Pruim J, et al. Predictive value of early 18F-fluoro-deoxyglucose positron emission tomography in chemosensitive relapsed lymphoma. Br J Haematol 2003; 123:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/65\">",
"      Derenzini E, Musuraca G, Fanti S, et al. Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B-cell non-Hodgkin lymphoma. Cancer 2008; 113:2496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/66\">",
"      Juweid ME, Wiseman GA, Vose JM, et al. Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography. J Clin Oncol 2005; 23:4652.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/67\">",
"      Schot BW, Zijlstra JM, Sluiter WJ, et al. Early FDG-PET assessment in combination with clinical risk scores determines prognosis in recurring lymphoma. Blood 2007; 109:486.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/68\">",
"      Juweid ME, Cheson BD. Role of positron emission tomography in lymphoma. J Clin Oncol 2005; 23:4577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/69\">",
"      Liedtke M, Hamlin PA, Moskowitz CH, Zelenetz AD. Surveillance imaging during remission identifies a group of patients with more favorable aggressive NHL at time of relapse: a retrospective analysis of a uniformly-treated patient population. Ann Oncol 2006; 17:909.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/70\">",
"      Moskowitz CH, Sch&ouml;der H, Teruya-Feldstein J, et al. Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in Advanced-stage diffuse large B-Cell lymphoma. J Clin Oncol 2010; 28:1896.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/71\">",
"      Cheson BD, Pfistner B, Juweid ME, et al. Revised response criteria for malignant lymphoma. J Clin Oncol 2007; 25:579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/72\">",
"      Shibuya H, Kamiyama R, Watanabe I, et al. Stage I and II Waldeyer's ring and oral-sinonasal non-Hodgkin's lymphoma. Cancer 1987; 59:940.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/73\">",
"      Saul SH, Kapadia SB. Primary lymphoma of Waldeyer's ring. Clinicopathologic study of 68 cases. Cancer 1985; 56:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/74\">",
"      Dodd GD. Lymphoma of the hollow abdominal viscera. Radiol Clin North Am 1990; 28:771.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/75\">",
"      Silverman JF, Geisinger KR, Raab SS, Stanley MW. Fine needle aspiration biopsy of the spleen in the evaluation of neoplastic disorders. Acta Cytol 1993; 37:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/76\">",
"      Moriarty AT, Schwenk GR Jr, Chua G. Splenic fine needle aspiration biopsy in the diagnosis of lymphoreticular diseases. A report of four cases. Acta Cytol 1993; 37:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/77\">",
"      Phillips G, Kumari-Subaiya S, Sawitsky A. Ultrasonic evaluation of the scrotum in lymphoproliferative disease. J Ultrasound Med 1987; 6:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/78\">",
"      Mazzu D, Jeffrey RB Jr, Ralls PW. Lymphoma and leukemia involving the testicles: findings on gray-scale and color Doppler sonography. AJR Am J Roentgenol 1995; 164:645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/79\">",
"      Charnsangavej C. Lymphoma of the genitourinary tract. Radiol Clin North Am 1990; 28:865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/80\">",
"      Rosenberg SA. Validity of the Ann Arbor staging classification for the non-Hodgkin's lymphomas. Cancer Treat Rep 1977; 61:1023.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/81\">",
"      Moormeier JA, Williams SF, Golomb HM. The staging of non-Hodgkin's lymphomas. Semin Oncol 1990; 17:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/82\">",
"      Anderson T, Chabner BA, Young RC, et al. Malignant lymphoma. 1. The histology and staging of 473 patients at the National Cancer Institute. Cancer 1982; 50:2699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/83\">",
"      Lee SM, Ryder WD, Clemons MJ, et al. Treatment outcome and prognostic factors for relapse after high-dose chemotherapy and peripheral blood stem cell rescue for patients with poor risk high grade non-Hodgkin's lymphoma. Bone Marrow Transplant 1999; 24:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/18/15658/abstract/84\">",
"      Shipp MA, Ross KN, Tamayo P, et al. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med 2002; 8:68.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4696 Version 14.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-190.111.122.2-14B9D587E9-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_18_15658=[""].join("\n");
var outline_f15_18_15658=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H43\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1150653658\">",
"      INITIAL LABORATORY STUDIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1150653623\">",
"      CBC and peripheral smear",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Bone marrow aspiration and biopsy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Renal function studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Immunoglobulin studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Other tumor markers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Lumbar puncture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      HIV serologies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Hepatitis B and C serology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Fertility preservation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      ROUTINE IMAGING STUDIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      CT scanning",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      PET scanning",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Initial evaluation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Evaluating response to treatment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Consensus opinion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      EVALUATION OF SPECIFIC SITES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Gastrointestinal tract",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Liver and spleen",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Central nervous system",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Skeletal imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Genitourinary tract",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      FUNCTIONAL TESTING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Cardiac function",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Pulmonary function",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Performance status",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      STAGING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H334141054\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H43\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"HEME/4696\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/4696|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?38/32/39427\" title=\"diagnostic image 1\">",
"      Lymphoma liver CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?3/43/3764\" title=\"diagnostic image 2\">",
"      Retroperitoneal nodes CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?26/26/27055\" title=\"diagnostic image 3\">",
"      Intussusception lymphoma CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?8/6/8290\" title=\"diagnostic image 4\">",
"      Lymphoma colon CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?1/1/1043\" title=\"diagnostic image 5\">",
"      Primary CNS lymphoma MRI II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?12/59/13233\" title=\"diagnostic image 6\">",
"      Lymphoma kidney",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?22/1/22544\" title=\"diagnostic image 7\">",
"      Lymphoma testis ultrasound",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/4696|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?41/2/42021\" title=\"figure 1\">",
"      Lymph node regions lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/4696|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?23/54/24416\" title=\"picture 1\">",
"      FL with leukemic cells",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?32/60/33728\" title=\"picture 2\">",
"      Burkitt lymphoma endosc",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?16/52/17231\" title=\"picture 3\">",
"      NHL rectum Endosc",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/4696|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?28/4/28749\" title=\"table 1\">",
"      Chemo associated nephrotoxicity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?12/35/12859\" title=\"table 2\">",
"      Risk neuraxis involvement NHL",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?29/27/30140\" title=\"table 3\">",
"      NHL treatment response criteria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/21/17757\" title=\"table 4\">",
"      Int prognostic index NHL",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?30/61/31708\" title=\"table 5\">",
"      Symptoms GI lymphoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?21/17/21787\" title=\"table 6\">",
"      Typical radiographic response in bone to select tumors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/11/2236\" title=\"table 7A\">",
"      Karnofsky performance status scale",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/15/9467\" title=\"table 7B\">",
"      ECOG performance scale",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?36/59/37819\" title=\"table 8\">",
"      Ann Arbor system in lymphoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?36/23/37243\" title=\"table 9\">",
"      Follic lymphoma int prog index",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?22/12/22732\" title=\"table 10\">",
"      NKPI for extranodal NK-T cell lymphoma nasal type",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/36/20042?source=related_link\">",
"      AIDS-related lymphomas: Epidemiology, risk factors, and pathobiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/31/12794?source=related_link\">",
"      Bleomycin-induced lung injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/22/5482?source=related_link\">",
"      Bone marrow aspiration and biopsy: Indications and technique",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/46/41706?source=related_link\">",
"      Cardiotoxicity of anthracycline-like chemotherapy agents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/2/44074?source=related_link\">",
"      Chemotherapy hepatotoxicity and dose modification in patients with liver disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/48/41738?source=related_link\">",
"      Chemotherapy-related nephrotoxicity and dose modification in patients with renal insufficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/27/6585?source=related_link\">",
"      Clinical features and diagnosis of neoplastic epidural spinal cord compression, including cauda equina syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/36/35400?source=related_link\">",
"      Clinical manifestations, pathologic features, and diagnosis of peripheral T cell lymphoma, not otherwise specified",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/46/25322?source=related_link\">",
"      Clinical manifestations, pathologic features, diagnosis, and prognosis of follicular lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/61/27610?source=related_link\">",
"      Clinical presentation and diagnosis of non-Hodgkin lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/32/8714?source=related_link\">",
"      Clinical presentation and diagnosis of primary gastrointestinal lymphomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/6/24680?source=related_link\">",
"      Epidemiology and clinical manifestations of chronic lymphocytic leukemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/47/762?source=related_link\">",
"      Epidemiology, pathogenesis, clinical manifestations and diagnosis of Waldenstr&ouml;m macroglobulinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/7/38010?source=related_link\">",
"      Fertility preservation in patients undergoing gonadotoxic treatment or gonadal resection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/25/26009?source=related_link\">",
"      Hepatitis B virus reactivation associated with immunosuppression",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/63/17402?source=related_link\">",
"      Initial treatment of mantle cell lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/6/19561?source=related_link\">",
"      Lumbar puncture: Technique; indications; contraindications; and complications in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/40/4744?source=related_link\">",
"      Overview of renal disease associated with malignancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/19/5433?source=related_link\">",
"      Pathobiology and treatment of histologic transformation in the indolent non-Hodgkin lymphomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?26/60/27588?source=related_link\">",
"      Patient information: Diffuse large B-cell lymphoma in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?8/9/8339?source=related_link\">",
"      Patient information: Follicular lymphoma in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?39/28/40386?source=related_link\">",
"      Patient information: Lymphoma (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/28/29127?source=related_link\">",
"      Prognosis of diffuse large B cell lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/58/10154?source=related_link\">",
"      Recognition of monoclonal proteins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/17/39194?source=related_link\">",
"      Secondary involvement of the central nervous system by non-Hodgkin lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/6/15466?source=related_link\">",
"      Staging and prognosis of chronic lymphocytic leukemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/23/10618?source=related_link\">",
"      Staging and prognostic studies in multiple myeloma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/49/20250?source=related_link\">",
"      Treatment-related toxicity in men with testicular germ cell tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/1/19481?source=related_link\">",
"      Tumor lysis syndrome: Definition, pathogenesis, clinical manifestations, etiology and risk factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/57/27541?source=related_link\">",
"      Uric acid renal diseases",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f15_18_15659="Risk factors for Achilles tendinopathy";
var content_f15_18_15659=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F81284&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F81284&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Important risk factors for Achilles tendinopathy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Stop-and-go sports (eg, basketball, soccer)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Previous Achilles tendon problems",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sudden increase in duration or intensity of running",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Male gender",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Obesity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Increasing&nbsp;age",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Poor running mechanics",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Over or under pronation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Flat foot (pes planus)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        High foot arch (pes cavus)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Leg length discrepancy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Foot malalignment",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fluoroquinolone&nbsp;or glucocorticoid use",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_18_15659=[""].join("\n");
var outline_f15_18_15659=null;
var title_f15_18_15660="Walk-run program";
var content_f15_18_15660=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F68511&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F68511&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Walk-run program",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\" rowspan=\"1\">",
"        General instructions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\" rowspan=\"1\">",
"        Focus on stretching after exercise, when the muscle-tendon units are warm and elasticity is increased, compared to stretching before exercise when the muscle-tendon units are cold, and less elastic.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\" rowspan=\"1\">",
"        Ice after exercise.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\" rowspan=\"1\">",
"        Do not do isometric or other restrengthening exercises immediately before walking or running.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\" rowspan=\"1\">",
"        If you have pain at any point during the program, rest a day, then start again on the previous level.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Day",
"       </td>",
"       <td class=\"subtitle1_single\">",
"        Walk",
"       </td>",
"       <td class=\"subtitle1_single\">",
"        Run",
"       </td>",
"       <td class=\"subtitle1_single\">",
"        Walk",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1-2",
"       </td>",
"       <td colspan=\"1\">",
"        5 min",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3-4",
"       </td>",
"       <td>",
"        10 min",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        5-6",
"       </td>",
"       <td>",
"        15 min",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        7-8",
"       </td>",
"       <td>",
"        20 min",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        9-10",
"       </td>",
"       <td colspan=\"1\">",
"        5 min",
"       </td>",
"       <td>",
"        5 min",
"       </td>",
"       <td>",
"        15 min",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        11-12",
"       </td>",
"       <td colspan=\"1\">",
"        5 min",
"       </td>",
"       <td>",
"        10 min",
"       </td>",
"       <td>",
"        10 min",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        13-14",
"       </td>",
"       <td colspan=\"1\">",
"        5 min",
"       </td>",
"       <td>",
"        15 min",
"       </td>",
"       <td>",
"        5 min",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        15",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        20 min",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_18_15660=[""].join("\n");
var outline_f15_18_15660=null;
var title_f15_18_15661="Moderate and severe alcohol withdrawal - Rapid overview";
var content_f15_18_15661=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F64745&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F64745&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Moderate and severe alcohol withdrawal: Rapid overview",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        <span style=\"color: #ff0000;\">",
"         To obtain emergent consultation with a medical toxicologist, call the United States Poison Control Network at 1-800-222-1222, or access the World Health Organization's list of international poison centers (",
"        </span>",
"        <a href=\"file://www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html\" target=\"_blank\">",
"         www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html",
"        </a>",
"        <span style=\"color: #ff0000;\">",
"         ).",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Syndromes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Alcohol tremulousness - occurs early, characterized by hypertension, tachycardia, tremors, and anxiety, with normal mental status",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Alcohol withdrawal seizures - occurs early, usually single or brief flurry of seizures with short post-ictal period",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Alcoholic hallucinosis - occurs early, no evidence of autonomic instability",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Delirium tremens - occurs late, characterized by delirium and autonomic instability",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        History",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pattern of alcohol use, history of withdrawal symptoms; inquire about reasons for cessation of alcohol",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Physical examination",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vital signs, mental status, presence of tremor; examine for signs of trauma, abdominal tenderness, other findings consistent with complications of chronic alcohol use",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Laboratory testing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        No test truly assesses withdrawal; ancillary data (eg, serum ethanol concentration, lumbar puncture (CSF), head CT, lipase) frequently needed to assess patient and rule out coexistent illness",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Treatment",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Benzodiazepines",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        First line therapy for ALL alcohol withdrawal syndromes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Most patients with symptoms require IV therapy initially",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        <strong>",
"         Give:",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Diazepam, 5 to 10 mg IV, repeat every 5 to 10 minutes,",
"        <strong>",
"         OR",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Lorazepam, 2 to 4 mg IV, repeat every 15 to 20 minutes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Massive doses (&gt;2000 mg diazepam in 48 hours) may be required",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Clinically stable patients with minimal symptoms may be treated with oral medications",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Barbiturates",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Synergistic with benzodiazepines; give if patient refractory to high-dose benzodiazepines",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Phenobarbital 130 to 260 mg IV, repeat every 15 to 20 minutes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Intubation frequently required with concurrent benzodiazepine and barbiturate use",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        ALL patients requiring barbiturates are monitored in an intensive care unit",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Propofol",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Excellent agent if patient refractory to benzodiazepines and barbiturates",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Intubation almost always required",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        1 mg/kg IV push as induction agent for intubation; titrate continuous infusion for sedation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Supportive care",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Assure adequate fluid and electrolyte replacement",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Give parenteral thiamine 100 mg and glucose daily",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Give multivitamin supplements",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Ensure adequate caloric support",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_18_15661=[""].join("\n");
var outline_f15_18_15661=null;
var title_f15_18_15662="Spiral enteroscopy overtube";
var content_f15_18_15662=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F76104&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F76104&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Spiral enteroscopy overtube",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 362px; height: 200px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Endo-Ease Discovery SB&reg; overtube for small bowel enteroscopy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Spirus Medical, Inc. Copyright &copy; 2010. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_18_15662=[""].join("\n");
var outline_f15_18_15662=null;
var title_f15_18_15663="Contents: Immunodeficiency states non HIV";
var content_f15_18_15663=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?15/21/15710\">",
"       Infectious Diseases",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Immunodeficiency states non HIV",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Immunodeficiency states non HIV",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Antibody deficiencies",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/52/21321\">",
"           Agammaglobulinemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/28/17866\">",
"           Clinical manifestations, epidemiology, and diagnosis of common variable immunodeficiency in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/45/38617\">",
"           Common variable immunodeficiency in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/32/21001\">",
"           Hyperimmunoglobulin M syndromes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/60/13258\">",
"           IgG subclass deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/16/35078\">",
"           IgG subclasses: Physical properties, genetics, and biologic functions",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/32/38409\">",
"           Intravenous immune globulin: Adverse effects",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/29/9688\">",
"           Pathogenesis of common variable immunodeficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/48/24326\">",
"           Primary humoral immune deficiencies: An overview",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/63/24570\">",
"           Selective IgA deficiency: Clinical manifestations, pathophysiology, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/17/30998\">",
"           Selective IgA deficiency: Management and prognosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/44/38597\">",
"           Selective IgE deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/11/42168\">",
"           Selective IgM deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/51/17209\">",
"           Selective antibody deficiency with normal immunoglobulins",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/47/30457\">",
"           Treatment and prognosis of common variable immunodeficiency",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Chromosomal breakage syndromes associated with immunodeficiency",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/60/23497\">",
"           Ataxia-telangiectasia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/42/35493\">",
"           Bloom syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/27/439\">",
"           Nijmegen breakage syndrome",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Combined immunodeficiency",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/27/2488\">",
"           Adenosine deaminase deficiency: Pathogenesis, clinical manifestations, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/43/27320\">",
"           Adenosine deaminase deficiency: Treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/42/28329\">",
"           CD3/T cell receptor complex disorders causing immunodeficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/58/40873\">",
"           Combined immunodeficiencies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/2/25637\">",
"           Purine nucleoside phosphorylase deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/52/15176\">",
"           Severe combined immunodeficiency (SCID) with JAK3 deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/30/42471\">",
"           Severe combined immunodeficiency (SCID): An overview",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/0/10\">",
"           Severe combined immunodeficiency (SCID): Specific defects",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/56/20362\">",
"           T cell negative, B cell negative, NK cell positive severe combined immunodeficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/26/25001\">",
"           T cell receptor signaling",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/18/1316\">",
"           X-linked severe combined immunodeficiency (SCID)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/2/42022\">",
"           ZAP-70 deficiency",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Immunodeficiency disorders - General considerations",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/26/43433\">",
"           Approach to the adult with recurrent infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/47/30458\">",
"           Approach to the child with recurrent infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/48/24328\">",
"           Assessing the immunologic response to vaccination",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/6/23656\">",
"           Flow cytometry for the diagnosis of primary immunodeficiencies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/51/33590\">",
"           Gene therapy for primary immunodeficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/2/1066\">",
"           Hematopoietic cell transplantation for primary immunodeficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/48/27401\">",
"           Immune and microbial mechanisms in the pathogenesis of inflammatory bowel disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/52/15178\">",
"           Immune function in older adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/48/14087\">",
"           Immune globulin therapy in primary immunodeficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/58/43945\">",
"           Laboratory evaluation of the immune system",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/27/8633\">",
"           Medical management of immune deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/9/31896\">",
"           Subcutaneous and intramuscular immune globulin therapy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Other",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/5/37978\">",
"           Pulmonary complications of primary immunodeficiencies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/22/40295\">",
"           Syndromic immunodeficiencies",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Other well defined immunodeficiency syndromes",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/36/30279\">",
"           Autoimmune lymphoproliferative syndrome (ALPS): Clinical features and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/58/30629\">",
"           Autoimmune lymphoproliferative syndrome (ALPS): Epidemiology and pathogenesis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/15/246\">",
"           Autoimmune lymphoproliferative syndrome (ALPS): Management and prognosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/51/7992\">",
"           Cartilage-hair hypoplasia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/1/22553\">",
"           Chronic mucocutaneous candidiasis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/12/22729\">",
"           DiGeorge syndrome: Clinical features and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/37/32343\">",
"           DiGeorge syndrome: Epidemiology and pathogenesis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/15/15608\">",
"           DiGeorge syndrome: Management and prognosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/25/32153\">",
"           Hyperimmunoglobulin E syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/15/25850\">",
"           IPEX: Immune dysregulation, polyendocrinopathy, enteropathy, X-linked",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/19/30009\">",
"           Idiopathic CD4+ lymphocytopenia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/26/426\">",
"           Idiopathic systemic capillary leak syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/8/12420\">",
"           Mannose-binding lectin",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/14/19690\">",
"           Mannose-binding lectin deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/12/4297\">",
"           Mendelian susceptibility to mycobacterial diseases (MSMD)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/10/30889\">",
"           NK cell deficiency syndromes: Clinical manifestations and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/39/4724\">",
"           NK cell deficiency syndromes: Treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/29/36313\">",
"           Wiskott-Aldrich syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/38/33384\">",
"           X-linked lymphoproliferative disease",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Phagocyte disorders",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/54/29542\">",
"           Acquired disorders of the complement system",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/18/42278\">",
"           Chediak-Higashi syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/36/10826\">",
"           Chronic granulomatous disease: Pathogenesis, clinical manifestations, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/12/11465\">",
"           Chronic granulomatous disease: Treatment and prognosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/22/24937\">",
"           Congenital neutropenia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/61/42966\">",
"           Cyclic neutropenia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/41/17048\">",
"           Determinants of neutrophil movement",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/33/42520\">",
"           Immune neutropenia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/58/42920\">",
"           Inherited disorders of the complement system",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/26/22953\">",
"           Leukocyte adhesion deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/60/14280\">",
"           Myeloperoxidase deficiency and other enzymatic WBC defects causing immunodeficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/37/10838\">",
"           Neutrophil-specific granule deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/25/10647\">",
"           Overview and clinical assessment of the complement system",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/47/18170\">",
"           Overview of neutropenia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/38/43620\">",
"           Primary disorders of phagocytic function: An overview",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Secondary immunodeficiency",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/24/7561\">",
"           Secondary immune deficiency due to miscellaneous causes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/0/29706\">",
"           Secondary immune deficiency induced by drugs and biologics",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/59/38842\">",
"           Use of antiinflammatory and immunosuppressive drugs in rheumatic diseases during pregnancy and lactation",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-6A2781EF8B-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f15_18_15663=[""].join("\n");
var outline_f15_18_15663=null;
